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ABSTRACT 
Campylobacter jejuni is the major cause of campylobacteriosis in humans. This thesis 
recorded the distribution of C. jejuni and C. coli isolates in a hospital environment 
during 1997/98. 105 clinical isolates of Campylobacter were examined usingflaA and 
gmhA PCR-RFLP analysis. Isolates were collected from 84 patients who presented at 
Christchurch Public Hospital or from the South Canterbury region. Males accounted for 
63.1 % of the sample. The largest number of cases was reported in the age group 20-29 
years. flaA specific primers were applied to all samples with 83.8 % generating a 1.7 kb 
amplicon. RFLP analysis using DdeI provided 17 different flaA profiles, with flaA 6 
being the most common type identified in this study. 82.9 % of the sample generated a 
distinguishable profile. This technique provided a D value of 92 % (D = Simpson's 
index of diversity). gmhA primers were also applied to this sample, with 71.4 % 
generating either a 900 bp, 1.6 kb or mUltiple band profile. 62.9 % of the sample 
provided a distinguishable RFLP profile. gmhA 1 was the most commonly observed 
profile. This technique provided a D value of 74 %. When combining these two 
genetic markers, discrimination was increased. 59 % (n=62) of the isolates had 
provided bothflaA and gmhA profiles. These isolates were distributed into 22 different 
classifications. MLEE analysis was applied to the largest flaA group in an attempt to 
further assess relationships. This analysis allowedflaA 6 to be subdivided into a further 
five groups, therefore increasing strain discrimination. PCR-RFLP procedures were 
highly reproducible, robust, discriminative and rapid to perform. However 17.1 % and 
37.1 % were untypeable by flaA and gmhA respectively. 
20 environmental (sheep) isolates from Massey University were also examined using 
flaA and gmhA PCR-RFLP analysis. Four flaA types and two gmhA types were 
observed amongst these isolates. The flaA and gmhA types had been previously 
observed in the clinical isolates, therefore suggesting that no strain was specific to a 
particular environment. However not all isolates were typeable with these two methods. 
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CHAPTER I 
INTRODUCTION 
1.1 DESCRIPTION OF THE GENUS. 
1.1.1 BASIC MORPHOLOGY AND PHYSIOLOGY. 
Members of the Genus Campylobacter are spiral or helical rods, 0.2 to 0.9 J-tm wide, 0.5 
to 5 I-Lm long, Gram-negative, non-spore-forming bacteria (Nachamkin 1992). Members 
of the Genus express polar, unsheathed flagellae and are actively motile using a 
corkscrew-like motion (Cover and Blaser 1989). The Generic name Campylobacter is 
derived from the Greek words campylo, meaning 'curved' and bacter, meaning 'rod' 
(Butzler and Skirrow 1979). Members of this Genus are important animal and human 
pathogens. 
Originally classified within the Genus Vibrio, Campylobacter spp. differ in a number of 
key respects, particularly in DNA base composition and the ability to replicate under 
conditions of reduced oxygen tension (Corry et al 1995). The DNA of Campylobacter 
spp. is typified by being extremely A+ T rich, with an average G+C content of 30 % 
(Nuijten et al1990a, Chang and Taylor 1990, Taylor 1992b). Most Campylobacter spp. 
require a microaerobic atmosphere of 5-7 % oxygen, 10 % carbon dioxide and 80 % 
nitrogen (Corry et al 1995, Nachamkin 1992). The presence of hydrogen at >7 % 
concentration has been observed to improve primary isolation of C. jejuni from faeces 
(Corry et al 1995). While members of this Genus replicate across a wide range of 
temperatures, the human pathogens have an optimal growth temperature of 42°C. The 
so-called "thermophilic" Campylobacter are C. jejuni, C. coli, C. upsaliensis and C. lari 
(Ketley 1995). Campylobacter jejuni is believed to be responsible for 90 % of all 
human campylobacteriosis (Wallis 1994, Stonnet and Guesdon 1993). 
1.1.2 TOLERANCE TO ENVIRONMENTAL STRESS. 
Interaction of a variety of factors such as temperature, salt and pH can determine 
whether numbers of Campylobacter will increase, decrease or remain static. C. jejuni 
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survives in moist foods, such as milk and chicken, more readily at 42°C than at ambient 
temperatures. Thermal inactivation occurs at temperatures above 48°C, while freezing 
reduces the culturable bacterial numbers. C. jejuni is relatively sensitive to sodium 
chloride, desiccation and pH (optimal growth is at pH 6.5 -7.5) (Christopher et al1982, 
Hasell1994). Under certain environmental conditions, such as exposure to atmospheric 
oxygen or nutrient limitation during stationary phase of growth, Campylabaeter spp. 
undergo a transition in morphology to round or coccoid forms (Ketley 1995). The 
morphological transition is associated with the organism going from a viable and 
culturable form to a viable, non-culturable form. This transition is suggested as an 
adaptation to survival under adverse conditions (Rollins and Colwell 1986). 
1.1.3 SIGNIFICANCE OF Campylabaeter AS A HUMAN PATHOGEN. 
Campylabaeter spp. were first recognised in the early decades of this century as a cause 
of infectious abortion and infertility in sheep and cattle (Allos and Blaser 1995). In 
1947 C. fetus was isolated from a pregnant woman who had had a septic abortion. This 
was the first reported case of pathogenicity in humans (AlIos and Blaser 1995). In 1972 
after the development of selective stool-culture techniques, C. jejuni was recognised as 
an important cause of acute diarrheal disease in humans (AlIos and Blaser 1995). 
C. jejuni and C. eali appear to share many clinical and epidemiological characteristics 
(Blaser et al1983) and campylobacteriosis caused by C. jejuni and C. eali is essentially 
indistinguishable. Therefore, interest in these organisms has been mainly for 
epidemiological purposes (Skirrow 1990). It may be possible that cases of 
campylobacteriosis due to C. jejuni may be over estimated due to difficulties in 
differentiating between C. jejuni and C. eali infection. 
1.2 INCIDENCE OF CAMPYLOBACTERIOSIS. 
In 1980 campylobacteriosis was made a notifiable disease in New Zealand and since 
then the incidence of infection has increased yearly (Faoagali 1984). For example, in 
December 1997 there were 1004 cases of campylobacteriosis notified, bringing the 1997 
total to 8747 cases. This is compared to 817 notified cases for December 1996 and a 
total of 7628 cases in 1996. The rate of campylobacteriosis rose in 16 of the 24 health 
districts, with six regions being above the national average for 1997 (Public Health 
rIl 
11.1 
~ 
U 
0 
Z 
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Report 1998). Figure 1 shows the increase in campylobacteriosis notifications in New 
Zealand from 1980 to 1997. 
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Figure 1: Increase in campylobacteriosis notifications in New Zealand from 1980 to 1997. (Adapted 
from the New Zealand Public Health Report and Communicable Disease New Zealand) 
1.3 EPIDEMIOLOGY. 
Males aged 1-4 and 20-29 years have the greatest incidence rate of campylobacteriosis. 
In fact, in all age categories males out-number females in rate of infection per 100,000 
population (AlIos and Blaser 1995, Butzler and Skirrow 1979, Blaser and Reller 1981). 
Brieseman (1994) observed that rural areas generally show a higher rate of infection 
than urban areas. Campylobacteriosis in the Canterbury region is primarily a 
spring/summer disease, peaking from November to March (Brieseman 1994). Figure 2 
shows the campylobacteriosis notifications in Canterbury during 1996 and 1997. 
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Figure 2: Campylobacteriosis notifications in Canterbury during 1996 and 1997. 
There are a number of natural reservoirs for Campylobacter spp.. Avian speCies, 
especially wild birds, are the major animal reservoirs of C. jejuni (Altekruse et al1994, 
Blaser and Reller 1981, Faoagali 1984, Rosef et al1983). C. jejuni has been isolated 
from the faeces of 30 to 100 percent of chickens, turkeys, water fowl and other wild 
birds. Campylobacter spp. have also been isolated from non-human primates, coyotes, 
dogs, cats and hamsters (Altekruse et al1994, Blaser and Reller 1981). Contact with 
infected animals can result in human infection. C. jejuni and other Campylobacter 
species are often present in stools of healthy dogs and those with diarrhea. Altekruse et 
al (1994) showed that dogs and cats with no signs of diarrhea were still positive for 
Campylobacter spp.. For instance in one clinic, 23 % of the dogs examined were 
asymptomatic carriers; while 21 % of the dogs examined were diseased. 
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Skirrow (1990) outlined three processes by which people become infected from animal 
flesh. These include: 
1) handling of raw product, 
2) consumption of raw or undercooked products, 
. 3) cross-contamination of 'innocent' foods. 
These scenarios are commonly observed with chicken consumption, or in the case of 
(3), consumption of salads or bread that have been cross-contaminated from raw meats. 
Chicken is frequently contaminated with Campylobacters, more so than red meats, and 
the level of contamination is often high. Pearson et al (1993) observed that in England 
and Wales, chicken was the second most common cause of Campylobacter infection. 
Most cases of campylobacteriosis from meat appears to be sporadic. 
Raw milk was the first documented source of human campylobacteriosis (Altekruse et 
al 1994, Blaser et al 1983). Campylobacter spp. commonly present in raw milk are 
thought to result from faecal contamination at time of milking. Occasionally cows 
excrete organisms into their milk from Campylobacter-caused mastitis (Skirrow 1990, 
Altekruse et a11994, Humphrey 1995). Robinson (1981) indicated that as little as 500 
organisms of C. jejuni suspended in milk will result in infection. Doyle and Roman 
(1982) carried out studies on raw grade A milk and reaffirmed the need for 
pasteurisation to limit C. jejuni. 
Water has also been linked to a number of outbreaks of campylobacteriosis. Waterborne 
outbreaks have been reported in the USA, Sweden, UK, NZ and elsewhere, and are 
generally associated with unchlorinated or under-chlorinated water (Brieseman 1987, 
Stehr-Green et a11991, Blaser et aI1983). Brieseman (1987) examined an outbreak of 
Campylobacter enteritis in Ashburton, New Zealand, in 1986. It was found that the 
onset of the disease related to discolouration and lack of chlorination of the water 
supply. Heavy rain occurred a few weeks prior to the outbreak. It was postulated that 
heavy rainfalls washed Campylobacter from the surrounding beef and sheep farms into 
the river, affecting the town water supply. A delay in chlorination of the municipal 
water supply after the rain may have allowed a portion of untreated water to enter the 
system (Brieseman 1987). Similar observations have been made previously regarding 
suspected water outbreaks (Blaser et al 1983, Stehr-Green et al 1991). However, 
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C. jejuni has rarely been cultured from a suspected water supply, thereby complicating 
the story. 
1.4 PATHOLOGY OF Campylobacter DISEASE. 
1.4.1 CLINICAL ILLNESS. 
The incubation period for campylobacteriosis ranges from one to seven days (Cover and 
Blaser 1989, Ketley 1995, Sahay et aI1995). The disease is characterised by symptoms 
such as fever, headache, muscular pain, nausea, vomiting and diarrhea (Humphrey 
1995, Butzler and Skirrow 1979, Blaser et al 1983). Many patients have at least one 
day with eight or more bowel movements (Blaser et aI1983). Diarrhoeic stools often 
contain fresh blood, muco-pus and an inflammatory exudate with leucocytes (Ketley 
1995). The faeces of patients who do not have chemotherapy usually remain positive 
for the organism for about two to five weeks after an attack of Campylobaeter enteritis. 
In mild cases patients may excrete the organism for only a few days of infection 
(Butzler and Skirrow 1979). 
Infective dose studies have been carried out to determine the number of organisms 
required for infection. Black et al (1988) found that 108 cells of C. jejuni resulted in a 
productive infection in 100 % of human volunteers in this trial (n=111), whereas as little 
as 500-800 bacteria suspended in milk or sodium bicarbonate could cause illness in 
>50 % of the sample. Black et al (1988) found the rate of infection (i.e., culture 
positive stools) increased with dose, but the development of illness did not show a clear 
dose response relationship. Infection with Campylobaeter does not always produce 
symptoms: asymptomatic excretors are commonly found associated with enteritis 
patients (Butzler and Skirrow 1979). Individual susceptibility to the organism and the 
relative virulence of the infectious strain are both important factors in the pathogenesis 
of Campylobaeter enteritis. 
1.4.2 PREVENTION AND TREATMENT OF CAMPYLOBACTERIOSIS. 
Enteric infection with C. jejuni is generally self-limiting, however relapses can occur in 
20 % of untreated cases (Lacey 1993, Blaser and Reller 1981, Reina et al 1994). 
Amongst those who do seek medical attention 30 to 100 percent recover without 
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specific antimicrobial treatment (Skirrow 1977, Karmali and Fleming 1979). However, 
anecdotal reports indicate rapid resolution of symptoms and fewer relapses after 
antimicrobial therapy (Skirrow 1977, Blaser et al 1979). Control and prevention 
measures for Campylobaeter infections are based on reduction of the reservoir in 
domestic animals or interruption of transmission to humans (Blaser et al 1983). Basic 
sanitary precautions are also required to prevent spread through animal contact. 
As stated earlier, C. jejuni is found in the environment and intestine of many food-
producing animals. Appropriate heating of foods and pasteurisation of milk are 
important measures useful in preventing infection (Altekruse et al 1994, Blaser et al 
1983). Possible human to human transmission is also important to interrupt. Stools 
from infected. infants and other incontinent persons represent the major human reservoir 
for transmission. Sanitary disposal of excreta and contaminated linens, and hand 
washing after contact are important to avoid infection (Blaser et al1983, Lacey 1993). 
Patients suffering diarrhea should not follow usual employment if it involves catering or 
health care (Lacey 1993). 
1.4.3 EXTRAINTESTINAL Campylobaeter DISEASES. 
Once established, a Campylobaeter infection can manifest in several different ways. 
The vast majority of C. jejuni infection is gastrointestinal in nature, but extraintestinal 
infections, including meningitis, urinary tract infection, reactive arthritis and Guillain-
Barre syndrome (GBS), have been reported (Walker et al 1986). GBS has become the 
most common cause of acute generalised paralysis, with an annual incidence of 0.75 to 
2 cases per 100,000 population (Ropper 1992, Mishu et al1993, Hughes 1991, Yuki et 
al 1995). GBS is an inflammatory, demyelinating disease, of peripheral nerves 
characterised by various degrees of weakness, sensory abnormalities and autonomic 
dysfunction (Hughes 1991, Ropper 1992). Although GBS has become the most 
common form of neuromuscular paralysis, its causes and pathogenesis are not clear 
(Rees et aI1995). In about two-thirds of patients, the neuropathic symptoms follow an 
often mild infection, such as an undiagnosed respiratory or gastrointestinal illness. 
Prior infection with C. jejuni is frequently associated with the onset of GBS (Rees et al 
1995, Lacey 1993, AlIos and Blaser 1995, Ho et al1995, Yuki et al1995, Mishu et al 
1993, Aspinall et aI1994b). It has been postulated that onset of paralysis usually occurs 
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1-3 weeks after the initial bacterial infection (Ropper 1992). There appears to be no 
relationship between severity of gastrointestinal symptoms and development of GBS. 
Rees et al (1995) observed that men were more likely to develop GBS after a C. jejuni 
infection than women. This may suggest a sex-linked predisposition, or reflect the 
greater number of males infected with C. jejuni than females. In the United States and 
Japan 30 % - 80 % of C. jejuni isolates from patients with GBS belong to Penner 
serotype HS:19 (AlIos and Blaser 1995, Kuroki et al1991, Fujimoto et alI992). The 
frequency of HS:19 strains amongst patients with gastroenteritis is often reported to be 
under 3 %, but may be as low as 1.2 % (MCMyne et al1982) 
Examinations carried out by Aspinall and colleagues on the structure of 
lipopolysaccharide (LPS) extracted from several C. jejuni strains found that the terminal 
regions of core oligo saccharides (OSs) of several serotypes of C. jejuni resembled the 
structure of human gangliosides. Yuki et al (1995) speculated that infection by C. jejuni 
strains expressing ganglioside-like epitopes induces the enhanced production of anti-
ganglioside antibodies in patients with certain immunologic backgrounds. This leads to 
loss of tolerance and the development of GBS. The commonly associated serotypes are 
HS:19 and HS:4, although other serotypes have been reported, these include HS:l, HS:2 
and HS:lO. Nachamkin et al (1996) observed, using polymerase chain reaction-
restriction fragment length polymorphisms within theflaA gene, that 80 % of the HS:19 
isolates were predominantly typed asflaA 21. However, otherflaA types were evident, 
these includedflaA 4 andflaA 70. 
Miller-Fisher syndrome (MFS) has also been linked to a prior C. jejuni infection. MFS 
is a neuropathy associated with ataxia, areflexia and ophthalmoplegia (Salloway et al 
1996). MFS is thought to occur when demyelination effects the cranial nerves. 
1.4.4 PATHOGENESIS. 
A reasonable understanding of the general clinical, microbiological and epidemiological 
aspects of Campylobaeter spp. infection has been achieved. However, the mechanisms 
by which Campylobaeter spp. induce disease are not well understood (Ketley 1995, 
Ruiz-Palacios 1992). The bacterial virulence factors, or determinants required to cause 
disease, are likely to be multifactorial in nature. Campylobaeter, being a predominantly 
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foodborne pathogen, must be able to resist and survive physiological stresses (e.g., 
environmental factors) present in food and water. This ensures successful transmission 
to a susceptible host and ultimately infection. The ability of Campylobacter spp. to 
enter a viable but non-culturable state may be of significance to this survival (Ketley 
1995). Mechanisms have been postulated by which C. jejuni induces illness. These 
include: 
1) adherence, production of enterotoxins, multiplication, colonisation and 
resistance of host defences, 
2) invasion and proliferation within the intestinal epithelium, resulting in cell 
damage and host inflammatory response (Ruiz-Palacios 1992, Ketley 1995, 
Cover and Blaser 1989). 
1.5 TYPING METHODS. 
1.5.1 INTRODUCTION. 
The development of a suitable typing system to discriminate between isolates within a 
species and between Genera is essential for epidemiological studies. Typing methods 
can provide information regarding relationships between isolates and determine the 
extent and possible sources of disease outbreaks. Since the recognition of 
Campylobacter spp. as major causes of human gastrointestinal disease, different typing 
schemes have been established for use in epidemiological studies (Kaijser and Megraud 
1992). Systems based on phenotypic and genotypic traits, having varying degrees of 
simplicity and discrimination, have been developed. Genotypic methods appear to be 
most sensitive, as these systems have the advantage of measuring stable chromosomal 
differences. These results are more consistent than biochemical and phenotypic tests 
which are variable under different culture conditions, and can be applied to all species 
because they possess DNA (Kaijser and Megraud 1992). 
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To be an effective epidemiological typing system several requirements must be met. 
These include: 
1) typeability and/or robustness - the ability to give an unambiguous positive or 
negative result for each isolate, 
2) reproducibility - the ability to provide an identical result when re-testing an 
isolate, 
3) discriminatory power - the ability to differentiate between epidemiologically 
unrelated strains. 
Additionally factors such as availability, cost, rapidity of the testing procedure and 
technical requirements (eg., equipment, personnel) also influence the typing system 
used. 
The next section will present an overview of typing techniques that have been applied to 
Campylobacter, and commentary on the relative usefulness and potential problems 
associated with each system. 
1.5.2 PHENOTYPIC TYPING METHODS. 
1.5.2.1 Resistotyping. 
Antimicrobial susceptibility testing (resistotyping) is a simple method to perform and 
interpret, measuring an isolate's resistance to various antimicrobial agents (Patton and 
Wachsmuth 1992). The usefulness of this test is dependent upon the organism's 
resistance to a variety of antimicrobial agents. Resistotyping has been found to 
correlate well with results from other schemes (Maslow and Mulligan 1996). Ribeiro et 
al (1996) examined Campylobacter resistance to a number of agents; tetracycline 
hydrochloride, metronidazole, 2,3,5-tetrazolium chloride, 5-fluorouracil, nalidixic acid 
and sodium arsenate. The level of reproducibility in this study was very good, with a 
test variation of <2 %. This research identified 35 resistotypes from 328 isolates, with 
the largest group consisting of 22 % of the isolates. Other investigators (Patton and 
Wachsmuth 1992) have found C. jejuni to be susceptible to most antimicrobial agents 
examined, therefore limiting the usefulness of this technique as a means for 
epidemiological typing. Resistotyping can be time consuming for C. jejuni when 
testing by agar MIC (minimal inhibitory concentration). However, Campylobacter 
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isolates received by the Center for Disease Control (CDC) are resistotyped to classify 
them into possible related groups. 
1.5.2.2 Auxotyping. 
Auxotyping has been used for typing of Campylobaeter strains (Dickgiesser and 
Czylwik 1985, Tenover et al1985, Tenover and Patton 1987). This technique exploits 
the different nutritional requirements necessary for growth of bacteria to distinguish 
between strains. In 1985 chemically defined media for auxotyping Campylobaeter 
strains were developed (Dickgiesser and Czylwik 1985, Tenover et al 1985). This 
technique requires no special equipment, large numbers of isolates can be tested 
simultaneously and it is an easily reproducible method. Campylobaeter auxotypes are 
consistent between laboratories and the system can be applied to other organisms with 
modification to accommodate diverse nutrient requirements (Sandstrom and Ruden 
1990, Tebbutt 1984). Tenover and Patton (1987) identified 12 auxotrophic patterns 
from approximately 500 US isolates. However, in this study fewer than half of the 
C. jejuni strains and none of the C. coli strains, exhibited auxotrophic requirements. 
Therefore auxotyping has limited usefulness in epidemiological studies. 
1.5.2.3 Biotyping. 
Biotyping of C. jejuni and C. coli strains has been widely reported. This technique is 
relatively simple to use (Patton and Wachsmuth 1992). Biotyping is based on the 
presence or absence of a biochemical function, e.g., fermentation of glucose. Each test 
is assigned a numerical value if a positive result is produced or a zero for no result. The 
sum of these tests is referred to as a biotype. This technique is similar to that of 
auxotyping. This procedure is mainly used in clinical laboratories to identify an 
organism to Generic or species level. The Preston biotyping scheme uses 12 tests, 
including 10 resistotyping tests that determine resistance to antibiotics, dyes and 
chemicals. 55 biotypes of C. jejuni have been identified (Patton and Wachsmuth 1992). 
However Lior's biotyping scheme, which uses hippurate hydrolysis, rapid H2S 
production and DNase activity, is the most widely used for distinguishing 
epidemiologically related strains, distinguishing 1,407 C. jejuni isolates into four 
biotypes (Lior 1984). Reproducibility of certain tests is poor and erratic, however this 
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may depend on the age of the culture medium, the incubation time or inoculum size of 
cultures, especially for the rapid H2S test (Skirrow and Benjamin 1980). 
1.5.2.4 Serotyping. 
Serotyping detects antigenic determinants that are expressed on the surface of a 
microorganism using specific (polyclonal but absorbed) antisera. Two principle 
schemes have been developed for C. jejuni, these include: 
1) Heat Stable (HS) antigens - developed by Penner and Hennessey (1980). 
Lipopolysaccharide (LPS) is the primary HS antigen used for differentiation 
of isolates in this scheme. This scheme identifies 60 serotypes (42 C. jejuni 
and 18 C. eali) (Aspinall et a11993a, Moran 1991). Antisera are specific for 
each species, and species can be serotyped separately. 
2) Heat Labile (HL) antigens - developed by Lior et al (1982), using outer 
membrane proteins as a marker, (e.g., flagella). This scheme identifies 108 
serotypes (8 among C. lari strains) (Patton and Wachsmuth 1992). 
Serotyping techniques are well developed and have been applied globally to identify 
Campylabaeter strains (Patton and Wachsmuth 1992). However, serotyping of C. jejuni 
is problematic as both HS and HL schemes require considerable time and labour 
investment to produce antisera (Owen et aI1995). Also a significant number of strains 
are nontypeable by either method (Patton and Wachsmuth 1992). More importantly, 
Owen et al (1994) studied the discrimination of serotyping in relation to other 
techniques available, such as biotyping and PCR-RFLP. They found that the 
discriminatory power of serotyping alone does not meet the requirements of a modem 
typing scheme. There was molecular evidence that strains within each serogroup were 
genetically diverse. When Penner serotyping was used in conjunction withflaA typing 
(see below) discrimination of C. jejuni isolates increased from 20 serotypes to 28 
unique clusters (Owen et al1994). Penner serotyping and PCR fingerprinting are two 
completely different typing methods; Penner serotyping detects phenotypic and PCR 
fingerprinting detects genotypic differences (Aarts et at 1995) therefore combining 
these two methods provided an increased level of isolate discrimination. 
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1.5.3 GENETIC TYPING SCHEMES. 
Molecular genotyping methods, based on chromosomal DNA analysis, are generally a 
more reliable method of characterising isolates as they are not dependent on expressed 
phenotypic features (Hernandez et al1995). Several methods which exploit precise and 
stable strain markers of Campylabaeter spp. have been developed. These include 
ribosomal DNA (rDNA) gene profiles obtained from Southern blot hybridisation and 
polymerase chain reaction (PCR) generated fingerprints using random primer sequences 
(RAPD-PCR) (Owen and Hernandez 1993). RAPD fingerprinting provides a 
discriminatory and rapid means of comparison of Campylabaeter isolates (Hernandez et 
al 1995, Armstrong 1997). Other methods include pulsed field gel electrophoresis 
(PFGE) and PCR-restriction fragment length polymorphism (RFLP) based on various 
genes, (e.g.,jlaA). 
1.5.3.1 Polymerase Chain Reaction (PCR). 
The advent of PCR has greatly accelerated the progress of studies on the genomic 
structure of various organisms (Hayashi 1994). PCR is recognised as a powerful tool in 
the detection of genetic alterations. Amplification of a specific segment of genetic 
material allows direct analysis of the relevant region of DNA without the background of 
the entire complex genome (Daniell 1994). PCR has several advantages over other 
typing methods, these include rapidity of results; low input material, requiring only a 
few cells of the microorganism and non-complex protocols (Swaminathan and Barrett 
1995). DNA can be prepared from fresh or frozen specimens using traditional 
extraction techniques. The simplest method of DNA preparation is to boil intact cells 
(Saiki et al 1986). This process simultaneously denatures and 'purifies' the DNA to 
allow PCR amplification. However, if too many cells (>50,000) are boiled, inhibition 
of the PCR can occur (Shibata 1994). Beyond simple detection of a pathogen, PCR 
technology can potentially provide genetic information relating to the virulence, 
chemosensitivity and epidemiological spread of a pathogen (Martin 1994). PCR has 
increasingly been used in the identification of many organisms. Viral infections due to 
the human immunodeficiency virus (HIV), human T-Iymphocytotropic virus (HTLV) 
and hepatitis viruses are just a few that the PCR technique has been applied to in order 
to characterise the organisms involved. Parasitic and fungal infections can also be 
detected by PCR (Martin 1994). PCR offers a highly sensitive and specific alternative 
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to selective enrichment for the detection and identification of bacterial pathogens (Hill 
et al 1990, Lampel et al 1990, Bej et al 1991). Noteworthy infectious bacterial agents 
examined include Mycobacterium and Borrelia burgdorferi, as well as Campylobacter. 
1.5.3.2 RFLP Typing Using the Flagellin GenesflaA and flaB. 
The flagella of C. jejuni is now recognised as an important virulence factor required to 
colonise the intestine of a host (Taylor 1992b, Newell et al1985, Morooka et al1985, 
Black et al 1988, Aguero-Rosenfeld et al1990, Pavlovskis et alI991). The flagellin 
genes have been cloned and extensively characterised (Taylor 1992b, Ketley 1995, 
Nuijten et al1990b). Two separate genes encoding flagellin,flaA andflaB, are present 
in the genome of C. jejuni and C. coli (Nuijten et al 1990b, Fischer and Nachamkin 
1991, Guerry et al1990). flaA and flaB are equally sized (approximately 1.7 kb), and 
are located adjacent to each other in a tandem (head to tail) orientation (Taylor 1992a). 
The flaA and flaB genes are transcribed independently and are regulated by different 
promoters (jIaA uses 0'28 whereas flaB uses a 0'54 promoter) (Nuijten et al1990b). flaA 
andflaB genes appear to be present in most of the C. jejuni and C. coli strains examined 
by DNA hybridisation analysis (Thornton et al1990). 
The flagellin gene flaA in Campylobacter spp. appears to have significant sequence 
heterogeneity and the gene has been used as a molecular epidemiological marker 
(Meinersmann et al 1997, Nachamkin et al 1993, Fischer and Nachamkin 1991, 
Thornton et al 1990). Most heterogeneity is found in the 5', 3' regions and a small 
central region of the gene (Harrington et al 1997, Ketley 1995, Sahay et al 1995, 
Waegel and Nachamkin 1996, Fischer and Nachamkin 1991). Nachamkin et al (1993) 
developed a PCR method to amplify the flaA gene of C. jejuni and used RFLP analysis 
of this gene to determine whether such a system would provide an alternative to 
serotyping. This PCR-based RFLP assay is sensitive, fast and reliable, and requires 
only minute amounts of DNA «50 ng) (Nishimura et al1996). 
Although fla gene-based assays have been applied successfully to analysis of faecal 
material, they do not offer a primary distinction between C. jejuni and C. coli (Linton et 
al 1997). Comi et al (1996) observed that the flaA primers are closely related to C. coli 
and C. jejuni but could not detect C. laridis and other organisms. It was concluded from 
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this research that flaA typing could not discriminate between C. jejuni and C. coli. 
Hippurate hydrolysis or a second molecular technique must be used to discriminate 
between these species. The study carried out by Linton et al (1997) showed that 
PCR-based detection, identification to the species level and typing of Campylobacter 
directly from faecal samples, was possible for clinical laboratories. Meinersmann et al 
(1997) carried out multiple sequence analysis of flaA from C. jejuni; this indicated as 
much as 30 % difference in the gene from one isolate to another existed. This supports 
Nachamkin's observations thatflaA typing could serve as an epidemiological marker. 
However PCR-RFLP assays are difficult to standardise and inter-laboratory 
comparisons of the results are especially difficult (Meinersmann et al1997). 
1.5.3.3 Randomly Amplified Polymorphic DNA-PCR (RAPD-PCR). 
RAPD-PCR fingerprinting of bacterial isolates was developed in 1990 (Welsh and 
MCClelland 1990, Williams et al1990). RAPD-PCR techniques use genomic DNA as a 
template and an oligonucleotide primer of arbitrary single-stranded DNA sequence 
(Williams et al 1990). The ability of RAPD-PCR to discriminate between isolates is 
dependent upon the selection of a suitable random primer (Lam et al1995). Hernandez 
et at (1995) observed that the RAPD-PCR method was a rapid means of comparing 
Campylobacter isolates and was discriminative in an intra-laboratory setting. However 
the DNA fragments generated are generally strain-specific; it is essential to know the 
Genus and species of the original organism. Usually the number of DNA fragments 
generated is dependent upon the ability of the primer sequence to detect a 
complimentary sequence in the target DNA. The distance of these sequences must be 
close enough to allow amplification, usually less than two kb apart. The generated 
profile may also depend upon the size of the target genome (Williams et aI1990). 
There are several advantages ofRAPD-PCR profiling. Swaminathan and Barrett (1995) 
observed that it is not necessary to have nucleotide sequence data available when 
designing primers to use. The same primers can be used for multiple applications. 
RAPD-PCR primers target the entire genome, resulting in a more complex and 
complete pattern than generated by PCR -RFLP procedures, therefore increasing the 
likelihood of demonstrating differences between strains. The PCR product does not 
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need to be purified, as restriction digesting of the PCR product is not performed. Berg 
et al (1994) found the RAPD method to be very sensitive, efficient and reliable. 
The greatest disadvantage of this technique is the lack of reproducibility of results. A 
minor change in PCR conditions may result in a different RAPD profile (Micheli et al 
1994, Mennier and Grimont 1993). Alterations in primer concentration, DNA template 
concentration and quality, Taq polymerase concentration and source, MgCh, the number 
of thermal cycles and even the model of thermal cycler used contribute to altering the 
reproducibility of this technique. 
1.5.3.4 Ribotyping. 
Ribotyping is a molecular technique based on hybridisation of a rRNA-DNA probe to 
restriction digested bacterial chromosomal DNA, measuring chromosomal differences. 
The technique involves generation of a labeled oligonucleotide probe, usually via PCR 
amplification of part of the 16S or 23S rRNA-DNA. The chromosomal DNA is 
digested with a restriction endonuclease and the digested DNA is transferred to a 
nitrocellulose or nylon membrane and probed with a radioactively labeled probe (Patton 
et alI991). Ribotyping can generate data relating directly to gene copy number, as well 
as serving as an epidemiological marker (Stanley et al 1993, Stanley et al 1994). 
Ribotyping has proved to be a sensitive marker allowing for a high level of 
discrimination amongst isolates at the species level, thus distinguishing C. jejuni from 
C. coli. This technique along with other genotypic procedures has the potential to 
provide more consistent, reproducible results and is applicable to other Genera and 
species. However, discrimination is dependent on the enzyme and probe chosen for 
hybridisation (Mourean et al1989, Owen et al1990, Patton et aI1991). Ribotyping is a 
complex procedure which requires specialised reagents and equipment, and skilled staff 
(Patton et al 1991). For routine use this technique would need to be more rapid, have 
fewer complex steps and use a non-radioactive label. This is possible with the PCR 
DIG probe synthesis kit. 
1.5.3.5 Pulsed-Field Gel Electrophoresis. 
PFGE involves the digestion of chromosomal DNA into large (several hundred 
kilobases) fragments using rare cutting restriction endonucleases (RE). This technique 
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has become increasingly popular as an epidemiological tool (Tenover et al 1995), 
allowing differentiation between species. PFGE has been applied to C. jejuni for 
chromosome mapping studies and epidemiological classification of isolates (Chang and 
Taylor 1990, Kim et al 1992). However the sensitivity of PFGE depends on the choice 
of restriction enzyme (Patton and Wachsmuth 1992). Taylor (1992b) found the 
restriction enzymes SalI and SmaI generated a manageable number of well-separated 
DNA fragments within the C. jejuni and C. coli chromosomes. Owen et al (1995) 
examined the discriminative ability of PFGE and found complete typeability of all 
C. jejuni strains was achievable. However, an inherent DNase activity present in some 
strains, which lead to premature DNA degradation, had to be overcome. This technique 
also requires expensive equipment, reagents and skilled staff. Significant time must 
also be spent on DNA preparation, electrophoresis and analysis. 
1.5.3.6 Multilocus Enzyme Electrophoresis (MLEE). 
MLEE has been used for many years in eucaryotic population genetics to estimate 
genetic diversity. More recently it has been used to estimate the genetic diversity and 
structure in natural populations of bacteria (Selander et al 1986). Selander's research 
established a basic population genetic framework to analyse variation in species of 
bacteria. This technique measures inheritable chromosomal characteristics by 
measuring the charge of enzymes, which translate to differences in enzyme migration. 
These results can be linked back to a specific change in the gene of an organism. 
MLEE has the ability to provide consistent and reproducible results. MLEE has proved 
useful as a marker for epidemiological studies, being based on the electrophoretic 
migration distances of enzymes present in most bacteria (Patton and Wachsmuth 1992). 
Different structural genes are represented by enzymes of cellular metabolism 
(Aeschbacher and Piffaretti 1989). Aeschbacher and Piffaretti (1989) observed that no 
electrophoretic type was shared between C. jejuni and C. coli, therefore indicating that 
this technique can distinguish between Campylobacter spp .. 
Data provided by MLEE allows identification of strains for epidemic purposes as well 
as acting as a measurement of genetic relatedness among strains within a species 
(Selander et al 1986, Aeschbacher and Piffaretti 1989, Patton et al 1991). Research 
carried out by Aeschbacher and Piffaretti (1989) found 50 and 14 electrophoretic types 
Chapter I Introduction 18 
among 104 C. jejuni and 21 C. coli strains respectively, demonstrating a high degree of 
genetic diversity within these two species. Unfortunately, MLEE is complex and is 
dependent on the number of enzymes analysed and the use of appropriate 
electrophoretic parameters (Patton and Wachsmuth 1992). In comparison to other 
genetic methods MLEE is relatively time consuming, for example PCR-RFLP analysis 
can be completed in 2 to 3 days, compared with 3 or more weeks required for MLEE 
(Patton and Wachsmuth 1992, Patton et aI1991). The technique may be best used to 
study population genetics of a large group of strains or where background data already 
exists (Patton and Wachsmuth 1992), for example, it could be used to further classify 
clinical isolates where a presumptive identification of Campylobacter has been made. 
1.6 LIPOPOLYSACCHARIDE. 
Lipopolysaccharide (LPS) is the major component (3-8 % dry weight of the cell) of the 
outer membrane of Gram-negative bacteria (Hancock et al 1994, Nikaido and Vaara 
1985). It is responsible for many of the protective properties of the outer membrane. 
LPS has been shown to contribute to several aspects of the infection process including 
eliciting cytotoxic effects, immunity to serum complement and protection from 
deleterious agents such as bile and hydrophobic antibiotics (Nikaido and Vaara 1985). 
C. jejuni LPS has been implicated in adherence to human epithelial cells and production 
of an endotoxin (McSweegan and Walker 1986, Moran 1995). C. jejuni LPS may also 
be involved in invasion/translocation into epithelial cells as has been demonstrated in 
E. coli and Salmonella typhimurium (Wallis 1994, Ketley 1995) but the role LPS plays 
in invasion may be secondary to that of the flagella (Klena et aI1998). 
LPS is composed of three functional domains. Anchoring the LPS to the outer 
membrane is a glucosamine-based glycolipid known as lipid A. A non-repeating core 
oligosaccharide is added at the non-reducing end of lipid A followed by the addition of 
a distal repeating polysaccharide or 0 antigen (Raetz 1990, Reeves 1994). C. jejuni 
strains showing the production of a high Mr LPS (with 0 antigens) e.g., strains HS:19, 
HS:23 and HS:36 are infrequent. Most strains produce predominantly a low Mr LPS 
similar to that observed with muscosal bacteria (containing no 0 antigens). 
Characterisation of the core oligosaccharides of C. jejuni serotypes HS: 1, HS:2, HS:3, 
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HS:4, HS:lO, HS:19, HS:23 and HS:36 (Aspinall et al 1993a, 1994a, 1994b) reveals 
variability in linkages and in constituents more closely resembling the 
lipooligosaccharides (LOS) of Neisseria and Haemophilus than the enterobacterial LPS 
(Moran 1995, Preston et alI996). 
Research has also implicated the LPS molecule in the development of GBS mentioned 
previously. Examination of the LPS structure from C. jejuni by mass-spectroscopy 
Aspinall et al (1992), found that the terminal regions of core oligosaccharides (OS) of 
several serotypes of C. jejuni mimicked the structures of human gangliosides. 
Serotypes HS:4 and HS: 19 yielded OS structures resembling the GMI and GDla 
gangliosides. Serotypes HS:l, HS:23 and HS:36 have shown GM2-like OS structures 
occur in LPS (Aspinall et alI992). The gangliosides, cell surface components of nerve 
tissue, are considered the target antigens of antineural antibodies (Yuki et al 1994). Sera 
extracted from GBS patients who previously had C. jejuni enteritis contains 
autoantibodies to GMI gangliosides during the acute phase of illness (Yuki et al 1994). 
C. jejuni isolates taken from patients with either GBS or Miller-Fisher syndrome (MFS) 
contain a characteristic terminal trisaccharide (Neu5Ac(a2-8)Neu5Ac(a2-3)~-D­
Galactose) structural feature not found in non-neuropathogenic strains (Salloway et al 
1996). The presence of N-acetyl neuraminic acid may cause increased resistance to 
human serum but the significance in C. jejuni pathogenesis in enteritis cases is uncertain 
(Salloway 1996). 
As mentioned previously the LPS molecule also forms the basis of the heat stable (HS) 
serotyping scheme of C. jejuni with up to 60 serotypes identified (Aspinall et al1993a, 
Moran 1991). C. jejuni LPS has considerable serological heterogeneity despite a 
relativity low number of carbohydrate antigenic determinants (Beer et al 1986, Perez-
Perez et al 1985). However common to all serotypes surveyed so far is a conserved 
inner core region composed of 3-deoxy-D-manno-octulosonic acid (KDO) and two 
heptose residues (Aspinall et alI993b). 
The heptose biosynthetic pathway is proposed to be composed of four enzymatic steps 
(Eidels and Osborn 1971). Figure 3 shows the heptose biosynthetic pathway, 
illustrating the enzymes and genes involved in the process. Recently, Brooke and 
. 
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Valvano (1996) provided biochemical evidence for the first enzymatic step. The 
conversion of sedoheptulose-7-P to D-glycero-D-mannoheptose-7-P is due to 
phosphoheptose isomerase (glycero-mannoheptose isomerase) in E. coli. Upritchard 
(1997) characterised the gmhA gene from C. jejuni and C. coli. The waaF gene, 
encoding a transferase necessary for the addition of a second heptose residue to the LPS 
core has also been identified adjacent to, but transcribed in a different orientation from 
gmhA in the strain NCTC 11168 and C. coli M275 (Upritchard 1997). Upritchard 
(1997) observed the gmhA gene to be transcriptionally coupled to adjacent genes and 
physically linked on the chromosome to other genes involved in the biosynthesis and 
attachment of heptose. For use as an epidemiological marker the gmhA gene identified 
by Upritchard was found to have sufficient heterogeneity between two species 
examined; 92.7 % identical, 95.1 % similarity of the GmhA protein of C. coli M275 
versus C. jejuni NCTC 11168 protein. Therefore this gene may act as a suitable 
epidemiological marker. Analysis of the recently submitted NCTC 11168 whole 
genome sequence has revealed this gene is unlinked to the flaA genel. The use of 
several unlinked genes with sufficient sequence heterogeneity could provide an 
increased level of discrimination for RFLP analysis. 
Sedoheptulose-7 -P 1 gmhA 
D-glycero-D-mannoheptose-7-P 
phosphoheptose 
isomerase 
phosphoheptose 1 gmhB 
mutase 
D-glycero-D- annoheptose-l-P 
ADP-Hep synthetase 1 gmhC· 
(ATPase) 
ADP-D-glycero-D-mannoheptose and pyrophosphate (PPi) 
epimerase I gmhD 
ADP-L-glyceri-D-mannoheptose 
transferase 
Innelore LPS 
Figure 3: Heptose biosynthesis pathway as proposed by Eidels and Osborn (1971) (adapted from Brooke 
and Valvano 1996). 
I The complete NCTC 11168 sequence is available at www.sanger.ac.uk. 
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1.7 OBJECTIVES OF THIS STUDY. 
Members of the Campylobacter Genus are important animal and human pathogens 
(Cover and Blaser 1989, Wallis 1994). C. jejuni causes 80-90 % of Campylobacter 
gastroenteritis worldwide (Skirrow 1990). Campylobacteriosis incidence has increased 
since 1980 in New Zealand, surpassing Salmonella, with the incidence in the 
Canterbury RHA amongst the highest in New Zealand. It is important to understand the 
relationship of C. jejuni strains present within a population. For example, if a particular 
isolate is observed in a clinical setting and is also observed in an environmental 
situation, a possible link may be determined. With increased understanding of 
relatedness and possible sources of infection, mechanisms could be put in place to 
reduce the number of infections and the seriousness of the disease. An awareness of 
inappropriate cooking practices may also serve to reduce the number of infections. In 
identifying the possible sources of infection, rates of campylobacteriosis may decrease. 
However, most of the cases reported are sporadic, therefore isolating a source is often 
difficult to achieve. 
Typing methods are important in epidemiological studies of C. jejuni. Many different 
systems are available, however, not all are reliable, robust, reproducible and 
inexpensive. A typing system with a high level of discrimination is needed that can be 
applied for routine use to analyse large numbers of C. jejuni. 
The aim of this study was to identify and characterise strains of C. jejuni and C. coli that 
were isolated from patients at Christchurch Public Hospital. It was decided to examine 
the isolates obtained from a hospital environment to determine whether these cases are 
more severe than those reported in the community. From the literature it was observed 
that most GBS cases have reported a previous Campylobacter infection. Most 
commonly HS:19 has been the C. jejuni strain responsible. By examining the cases of 
C. jejuni and C. coli isolated from Christchurch Public Hospital, evidence could be 
provided as to what strain may have been present in a patient who subsequently 
developed GBS. GBS cases in New Zealand are rare, with only 1-2 cases reported a 
year. Due to the rarity of this illness, this study was not able to identify a GBS related 
isolate. Therefore, this study concentrated on identifying and classifying the strains 
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present in a hospital environment to determine if they were different from those 
reported in the community. 
To characterise the strains two established techniques were applied. One technique, 
PCR -RFLP using the jlaA and gmhA genes was used. These two genes are unlinked on 
the Campylobacter genome, therefore providing meaningful discrimination when used 
in conjunction. The second technique, MLEE, was applied to the largest jlaA group 
identified to determine if this subset could be discriminated further. 
Concurrently to the clinical characterisation, C. jejuni isolated from sheep were also 
examined by PCR-RFLP ofjlaA and gmhA. This was to determine whether there was a 
clonal difference between sheep (environmental) isolates and those observed in a 
clinical setting. 
This research will also help to establish a database of isolates gathered from different 
sources, i.e., humans and animals. These results can be added to previous studies which 
have identified C. jejuni from water supplies and a second human source, isolated from 
non-hospitalised campylobacteriosis sufferers (Armstrong 1997). From this study the 
relatedness of isolates gathered from hospitalised patients, and those previously 
observed from gastroenteritis cases (Armstrong 1997), can be compared to determine 
relatedness and distribution between these environments. In future experiments, results 
will be able to be compared and added to this database as necessary. Over time, this 
will increase our knowledge of Campylobacter isolates in different environments, 
ascertaining whether certain Campylobacter types are adapted to one environment and 
whether certain isolates are more virulent than others. 
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MATERIALS AND METHODS 
2.1 BACTERIAL STRAINS. 
The bacterial strains used in this study are listed in Table 1. 
Table 1: List of bacterial strains used in this study. 
NCTCl1168 
XT318V 
XV898P 
XX158F 
YG018S 
YG023Q 
IG022P 
XM653F 
YJ936T 
Y0808T 
YF567F 
YN438B 
YP502F 
YU298M 
YU304J 
BB193H 
BL821U 
BM271M 
BN499U 
BV3740 
CE934Q 
CA7551 
CIl15W 
CM123F 
CU130P 
ZB375B 
ZB632B 
D0399V 
DN031T 
D0332T 
D0291I 
EG5460 
EG761C 
ET973Q 
EU369T 
EX923G 
FD131W 
ZF320J 
FZ917J 
GF923R 
HFNZRM 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
YG018S 
YG018S 
Y0808T 
BM271M 
BV3740 
DN031T 
DN031T 
EG5460 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
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Table 1. Continued ... 
ZG339F 
CR828J 
RI88IO 
HW961T 
ZH604N 
ZH6050 
ZH606P 
ZH641W 
ZI814K 
JF124L 
ZI975L 
ZJ271C 
ZJ638R 
LJl55C 
LB445E 
LG430P 
LG794W 
LC667G 
LB244Q 
KX649A 
KZ3861 
KV955A 
R923 
S052 
LS897W 
LS785M 
LT038S 
LT973B 
LR181R 
LS466P 
MB200L 
MB321A 
MB617S 
MD672W 
MC715F 
MC591P 
MS179P 
PH790A 
PH844R 
PH845S 
PF322Q 
PD850L 
PA268R 
MZ347T 
MM539G 
ZN244B 
PN728G 
ZN474U 
QA598G 
ZN807W 
QZ233U 
QP453U 
QM664N 
RE097T 
RF185D 
QZ840M 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HBCHL 
HBCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HBCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
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ZH604N 
ZH604N 
KZ3861 
LS785M 
MB200L 
PH790A 
PH790A 
PA268R 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. coli 
C. coli 
C. coli 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C. jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C. jejuni 
C. jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
C. jejuni 
C.jejuni 
C.jejuni 
C.jejuni 
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Table 1. Continued ... 
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RC703J HF CHL QZ233U C.jejuni 
RE 1590 HF CHL C. jejuni 
RC7220 HF CHL C. jejuni 
RC317T HF CHL C. jejuni 
QZ550A HF CHL QZ840M C. jejuni 
ZP028D HF CHL C. jejuni 
QY139W HF CHL C. coli 
RC167B HF CHL C. coli 
RD 177L HF CHL C. coli 
CJS-71 Sheep C. jejuni 
CJS-72 Sheep C. jejuni 
CJS-73 Sheep C. jejuni 
CJS-74 Sheep C. jejuni 
CJS-75 Sheep C. jejuni 
CJS-76 Sheep C. jejuni 
CJS-77 Sheep C. jejuni 
CJS-78 Sheep C. jejuni 
CJS-79 Sheep C. jejuni 
CJS-80 Sheep C. jejuni 
CJS-81 Sheep C. jejuni 
CJS-82 Sheep C. jejuni 
CJS-83 Sheep C. jejuni 
CJS-84 Sheep C. jejuni 
CJS-85 Sheep C. jejuni 
CJS-86 Sheep C. jejuni 
CJS-87 Sheep C. jejuni 
CJS-88 Sheep C. jejuni 
CJS-89 Sheep C. jejuni 
CJS-90 Sheep C. jejuni 
HF CHL = Human Faeces Canterbury Health Laboratories. 
HB CHL = Human Blood Canterbury Health Laboratories. 
HF NZRM = Human Faeces, New Zealand Reference Material. 
CJS = Campylobacter jejuni sheep. 
2.1.1 SOURCE OF ISOLATES. 
25 
Isolates were collected from Canterbury Health Laboratories (CHL) from Mar~h 1997 
until March 1998. Campylobacter jejuni was mainly isolated from stool samples of 
patients who presented at Christchurch Public Hospital with gastrointestinal illness. 
However, three isolates were obtained from blood samples taken from patients who 
presented to Christchurch Public Hospital with bacteremia during this period. 
Campylobacter jejuni and Campylobacter coli isolates were initially cultured from 
stool/blood on Campylobacter Charcoal Differential Agar (CCDA, Oxoid) and 
incubated in the laboratory at 42°C in an atmosphere containing 10 % CO2 for 48 h. 
Dr Stan Fenwick (Massey University) provided twenty C. jejuni isolates from 
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slaughtered sheep. 
2.2 BUFFERS AND MEDIA. 
Solutions and media used in this study were prepared as described in appendix 1. 
2.2.1 ANTIBIOTICS. 
Cefoperazone (Cp) was added to molten CCDA media in order to select for 
Campylabaeter. Cp was added to a final concentration of32 Ilg/ml in this study. 
2.3 BACTERIOLOGICAL METHODS. 
2.3.1 CULTURE CONDITIONS. 
Campylabaeter jejuni and C. eali isolates were incubated in a water-jacketed C02 
incubator (Nuaire) in a microaerophilic environment of 10 % CO2. Incubation 
temperatures were either 37°C or 42°C and solid media (CCDA with the addition of Cp 
or Mueller-Hinton Agar containing 5 % defibrinated sheep's blood) was used. 
2.3.2 IDENTIFICATION OF C. jejuni AND C. eali. 
Moist, flat, grey, spreading colonies visible on the CCDA media were presumptively 
identified as C. jejuni. The 48 h old bacterial colonies were Gram-stained to visualise 
the organisms. Nalidixic acid sensitivity was used to distinguish different 
Campylabaeter spp. (Tenover et al 1992). Nalidixic acid sensitive isolates were 
examined using hippurate hydrolysis. Differentiation of C. jejuni from C. eali relies on 
the ability of C. jejuni to hydrolyse hippurate (Linton et al 1997). Gram-negative, 
nalidixic acid sensitive and hippurate positive organisms were considered to be C. jejuni 
(Nachamkin 1992). 
2.3.3 STORAGE OF STRAINS. 
For day to day use isolates were maintained on CCDA plates supplemented with Cp at 
37°C or 42°C in an atmosphere containing 10 % CO2. Long term storage of isolates 
was achieved by harvesting bacterial growth from CCDA plates using Brain Heart 
Infusion broth (Gibco BRL) containing sterile glycerol (BDH) (final concentration of 
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20 %) using a sterile glass rod. A 1.5 ml aliquot was mixed with 6-8 (2.5 to 3.5mm 
dia.) sterile glass beads (BDH) contained in Nunc cryotubes. Aliquots of isolates were 
stored at -80a C until required. 
2.4 ANALYTICAL TECHNIQUES. 
2.4.1 POLYMERASE CHAIN REACTION. 
Polymerase chain reactions (PCR) of bacterial DNA were performed using a Corbett 
Research FTS-320 Thermal Sequencer. Taq polymerase and buffers were purchased 
from Qiagen, dNTPs were purchased from Gibco-BRL and primers (Table 2) were 
purchased from Amrad-Pharmacia Biotech. 
Table 2: PCR Primers. 
94.293 5' -GCA ATA AAA CCA CTA TCA-3' waaF C jejuni 
96.01 5'-CAA GAG TTGAATTGATCG-3' gmhA Cjejuni 
96.11 (pg 50) 5'-ATG GGA TIT CGT ATT AAC-3' flaA Cjejuni 
96.17 (NR 2) 5' -CTG TAG TAA TCT TAA AAC ATT TTG-3' flaA Cjejuni 
Each PCR consisted of several reagents added to a thin-walled 0.5 ml Eppendorf tube 
(all concentrations are final for 100 III reactions): 3 pmoi/Ill of each primer (forward 
and reverse), 250 IlM dNTP (dGTP, dATP, dTTP, dCTP), 3 mM MgCh, and sterile 
ddH20. Using a sterile pipette tip, a bacterial colony was removed from a CCDA plate 
and added to a mixture containing the above reagents (89.5 Ill). The reactants were 
placed in the thermal sequencer and DNA templates were denatured by incubation at 
99°C for 10 min. Tubes were briefly cooled to ambient temperature by incubation at 
25°C for 1 minute. Mixtures were microfuged for 5 seconds at 13,400 x g before the 
addition of lOx PCR buffer (containing 15 mM Mg2+) and 2.5 U Taq polymerase, 
bringing the final volume of each reaction to 100 Ill. Mixtures were briefly pulsed in 
the centrifuge to collect all components of the reaction. Reaction mixtures were 
overlaid with 100 III of sterile paraffin oil and returned to the thermal sequencer. PCR 
amplification consisted of the following cycling conditions: 94°C for 1 min to denature 
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template followed by 35 cycles of 94°C for 15 sec, an annealing step of 55°C for 45 sec, 
and extension of templates at 72°C for 1 min and 45 sec (Nachamkin 1996). A 36th 
cycle in which the denaturing/annealing conditions were the same, except the final cycle 
was extended to 5 min at 72°C to allow for completion of all initiated products was 
added. PCR products were removed from under the paraffin oil, transferred to a sterile 
1.5 ml tube and stored at -20°C. Control reactions containing all reagents except 
bacterial DNA served as a negative control. C. jejuni strain NCTC 11168, known to 
reliably produce an amplicon with the chosen primers, was used for a positive control. 
Control reactions were performed with every PCR procedure. 
2.4.2 RESTRICTION FRAGMENT LENGTH POLYMORPHISMS. 
The restriction endonuclease DdeI (Boehringer Mannheim) was used to detect 
restriction fragment length polymorphisms (RFLP) in genes amplified from C. jejuni 
isolates. flaA and gmhA PCR amplicons generated by the described PCR conditions, 
were examined by DdeI digestion and electrophoresis to determine their respective 
RFLP profiles. In all cases the PCR generated amplicon was used directly for RFLP 
analysis, no clean up procedure was performed. Restriction endonuclease digestion 
reactions were carried out according to the manufacturer's protocol using buffers 
supplied. Reactions were performed in a final volume of 15 III and incubated at 37°C 
for 3 hours. The extent of restriction endonuclease digestion was determined by agarose 
gel electrophoresis, followed by staining of DNA fragments with ethidium bromide, and 
visualisation using a UV transilluminator (302 nm). 
2.5 AGAROSE GEL ELECTROPHORESIS OF DNA. 
Amplicons from PCR reactions and amplicons modified by restriction endonuclease 
digestions were separated by Tris-acetate-EDTA (TAE) buffered agarose gel 
electrophoresis. Agarose was dissolved in 1 x TAE buffer (appendix 2) to give a final 
agarose concentration ranging from 0.8 % (to resolve high molecular weight DNA 
fragments) to 4 % (for resolution of DNA fragments <0.5 kb, generated by DdeI 
digestion). DNA samples were mixed with 2 III of 6 x gel loading buffer (appendix 2) 
before loading into a preformed agarose well. PCR-RFLP amplicons were separated 
using an electric field of 50-100 volts for 1-2.5 hr in either a mini-sub (Bio-Rad) or 
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submarine electrophoresis cell (Jordan) apparatus, connected to either a Model 
1,000/500 (Bio-Rad) or a Mighty-Slim 5 X 250 (Hoefer) power supply. DNA was 
stained with ethidium bromide (0.5 f..lg/ml) in 1 x TAE for 15-20 min. DNA fragments 
were visualised using a Sigma T2210 UV (302 nm) transilluminator or an Ultra-Lum 
KS-3000 Visualisation-Documentation and Analysis system (Ultra-Lum, Carson, CA). 
2.6 ANALYSIS OF RFLP PATTERNS. 
PCR-RFLP patterns were photographed using Polaroid film (Black and white instant 
pack film 667) to allow for permanent storage and companson. Alignment and 
comparison of patterns was performed manually. When undertaking RFLP 
experiments, NZRM 1958 (NCTC 11168) was used as a positive control to ensure 
reproducibility between experiments. This also enabled gel comparisons between each 
experiment. When an isolate provided a profile similar to that of another isolate, both 
isolates were subjected to RFLP analyses again and visualised on an agarose gel. This 
technique demonstrated whether the isolates were identical or if a variation existed, 
therefore allowing classification into different RFLP profiles. This procedure allowed 
accurate determinations to be made of the isolates examined using PCR-RFLP. The 
same molecular weight marker (100 bp DNA ladder, Promega) was used in each 
experiment. On the basis of visual comparisons each RFLP profile was assigned to a 
particular flaA or gmhA classification. 
2.7 MULTILOCUS ENZYME ELECTROPHORESIS. 
2.7.1 BUFFERS AND ENZYMES. 
The buffers and enzymes used for multilocus enzyme electrophoresis in this study are 
listed in appendix 3. 
2.7.2 ISOLATE PREPARATION. 
Fifteen clinical strains of C. jejuni (based on their flaA classification) were cultured on 
CCDA at 42°C in 10 % CO2, for 48 h. A single colony from each strain was restreaked 
onto Nutrient Broth No.2 agar (appendix 1) and cultured at 42°C, 10 % C02, for 48 h. 
After this time 30 ml Nutrient Broth No.2 (appendix 1) was inoculated with a bacterial 
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suspension taken from the plate using a sterile 1 J.ll plastic loop and incubated at 42°C, 
in 10 % CO2 for 48 h. The entire bacterial culture (estimated to contain 2 x 108 cfulml 
as determined by serial plate counts) was transferred to 30 ml Oakridge centrifuge tubes 
(Nalgene) and centrifuged at 13,800 x g, 4°C for 10 min. The bacterial pellet was 
resuspended in 1 ml of extraction buffer (appendix 3), and transferred to a sterile 2 ml 
polypropylene tube. The bacterial suspension was mixed with 2 g of 0.1 mm Zirconium 
silicate beads (BioSpec Products) and shaken at 5,000 rpm for 30 sec in a Mini 
Beadbeater Cell Disrupter (BioSpec Products). Samples were incubated on ice until all 
isolates had been lysed; the procedure was repeated to ensure complete lysis. The 
polypropylene tubes were pulsed briefly «5 sec) in a microfuge to collect the silicate 
beads. Supernatants were transferred to a sterile 1.5 ml Eppendorf tube and centrifuged 
at 6,600 x g, 4°C, for 3 min. Celllysates were stored at -80DC until required. 
2.7.3 MLEE ELECTROPHORETIC TECHNIQUE. 
TG Buffer (appendix 3) was loaded into each well of a Helena electrophoresis apparatus 
(Helena Laboratories, Texas, USA). A filter paper wick was placed over the edges of 
the inner region of the electrophoresis apparatus ensuring it was immersed in the tank 
buffer. Cellulose acetate plates (7.5 cm x 7.5 cm) were soaked in TO Buffer (appendix 
3) and incubated at ambient temperature for 15-20 min. A 10 J.ll aliquot of each sample 
was loaded into a sample well of the sample loading plate (maximum 12 samples). 
After blot drying briefly with Whatman 3 mm filter paper, bacteriallysates were applied 
to the cellulose acetate plate using a Super Z-12 applicator supplied by the 
manufacturer. An aligning base was used to assist sample loading onto the cellulose 
acetate plate. Plates were placed face down onto the filter paper wick to ensure 
connection. The electrophoresis apparatus was connected to a Mighty-Slim 5 X 250 
(Hoefer) power supply. Undenatured enzymes were separated by exposure to an 
electric field of 100-200 volts for 20-25 mins; 6 x agarose gel buffer served as an 
indicator of enzyme migration. When the blue indicator dye was 1 cm from the 
cathode, electrophoresis was discontinued and cellulose acetate plates were stained 
immediately in the appropriate detection buffer (appendix 3) and incubated at 3JOC for 
20-30 mins to allow visualisation of the colourimetric product. 
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2.7.4 MLEE DETECTION. 
To enhance enzyme detection numerous variations of the experimental procedure were 
performed. Experimentation with the pH of TO Buffer was investigated; pH values of 
7.0, 7.5 8.0 and 8.5 were trialled to determine the optimum pH for the buffer system. 
Both the buffer that the cellulose acetate plates soaked in and the electrode buffer were 
of the same pH. Four enzymes were trialled during this protocol. These were malate 
dehydrogenase NADP+ (ME), malate dehydrogenase NAD+ (MDH), phenyalanine-
leucine peptidase (PEP) and catalase (CAT) (appendix 3). 
In addition to varying pH, enzymes were detected with or without an agar overlay 
(appendix 3) (Selander et al 1986, Hebert and Beaton 1989). Initially the agar was 
applied to the cellulose acetate plate following application of the desired stain to the 
plate with poor results. The second attempt was to apply the agar to the cellulose 
acetate plate prior to the stain being applied; again with poor results. The agar was 
incorporated into the desired stain (generally equal volumes), mixed briefly, and applied 
to the cellulose acetate plate before hardening of the agar. This third procedure was 
found to yield the best results and therefore used for subsequent experiments. 
Staining for ME, MDH and PEP was carried out at 37°C for 20 min. If no bands were 
evident after the initial 20 min, the cellulose acetate plate was incubated for an 
additional 10 min. If no bands were evident after this time a negative result was 
recorded. The cellulose acetate plates were rinsed for 20 min in H20 to remove the agar 
overlay, and a photo taken. Cellulose acetate plates were allowed to air dry at ambient 
temperatures or were placed in an oven at 55°C for 10 min. Plates could be rehydrated 
with H20 for future analysis. 
Staining for CAT was always performed at ambient temperature. Initial electrophoretic 
conditions were as described above, however it was found that at 100 V, the migration 
of the samples was uneven and samples did not migrate as quickly as during the 
previous experiments. Due to slow enzyme migration the electric current was 
discontinued when the blue indicator dye was half way along the plate. Staining was as 
described by Aeschbacher and Piffaretti (1989). Briefly, plates were incubated at 
ambient temperature in a 50 ml solution of 50 % (w/v) sodium sulfite and hydrogen 
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peroxide for 15 min, followed by a brief rinse with distilled H20. To stain for catalase, 
cellulose acetate plates were immersed in freshly made 1.5 % (w/v) potassium iodide 
and agitated gently. Plates were removed from the staining solution when white zones 
appeared on a dark blue background. 
2.7.5 INTERPRETATION AND SCORING OF ALLELES. 
Scoring of alleles on the cellulose acetate plates was performed by visually assigning 
the slowest migrating band as a 1; the next slowest as a 2 and so on. If a particular 
strain had two alleles it was assigned two numbers. For example, the slowest migrating 
allele a 1 and the fastest migrating allele a 4. 
2.8 ANALYSIS OF PATTERNS. 
2.8.1 S-PLUS. 
Profiles generated by PCR-RFLP and MLEE were analysed using the S-plus package 
(appendix 4) and a dendrogram showing relatedness of isolates generated. For PCR-
RFLP each band was assigned an allele in order of migration, with the slowest 
migrating band being designated a 1, until all bands had been assigned (appendix 5). 
Bands that were under 100 bp were not assigned a number as separation at this point 
was difficult to visualise. The profiles were then applied to the statistical package and a 
dendrogram generated. 
2.8.2 DISCRIMINATION VALUE. 
The level of discrimination was calculated for all typing methods, to determine the 
effectiveness of these methods as epidemiological markers. The D value was calculated 
using Simpson's index of diversity: 
s 
D = 1 - 1 L nj (nj - 1) 
N(N-1) j=l 
Where N is the total number of strains in the sample size; s is the total number of types 
described and nj is the number of strains belonging to the /h type (Hunter and Gaston 
1988). 
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CHAPTER III 
RESULTS 
3.1 CLINICAL ISOLATE INFORMATION. 
In this study 105 isolates of Campylobacter spp. obtained from human faeces or blood 
were examined. Isolates were collected from Canterbury Health Laboratories (CHL) 
from March 1997 to March 1998. Figure 4 shows the number of isolates collected each 
month as part of this study relative to the number of Campylobacter infections reported 
to the Southern Regional Health Authority (SRHA). Overall 10.8 % of the 
campylobacteriosis cases reported were examined during this study. The sample size of 
this study was limited to patients who were hospitalised in Christchurch and from the 
South Canterbury region. A majority of the cases reported to the SRHA would not have 
been admitted to hospital and did not fit the scope of this investigation. 
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Figure 4: Campylobacter infections in the Canterbmy region 1997-98. 
CHL = Canterbmy Health Laboratories. 
SRHA = Southern Regional Health Authority. 
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Of the 105 clinical isolates three (2.9 %) were isolated from the blood of patients, the 
remaining 97.1 % were obtained from faeces. In this study six isolates (5.7 %) were 
identified as C. coli while the remaining 94.3 % were classified as C. jejuni. The 
identification of isolates to species level was performed by Gram-staining, nalidixic 
acid sensitivity and hippurate hydrolysis. 
In this study 84 patients were examined. These patients provided 105 isolates with 15 
providing multiple isolates during the course of illness, either 2 or 3 samples. Table 1 
(Chapter 2, p 23) shows the relationship of isolates to one another, listing the reisolated 
samples. Demographic data relating to age, sex and geographic location was collected 
(appendix 5). For one patient no information was provided. Of the remaining 83 
patients, 64.3 % (n=54) were males, while 34.5 % (n=29) were females. This study 
supports the observations reported in the literature that males are more prominent in 
suffering from campylobacteriosis than females. 
There are two dominant age groups that suffer from campylobacteriosis. These are 1-4 
years and 20-29 years of age. From this study it was observed that 20-29 year olds 
represented the largest number of infections (n=27), with males representing 19 cases. 
However the 1-4 age group did not follow this trend, with only five cases of which 
males accounted for four. This study showed the age group 30-39 years to have the 
second largest number of infections, with 16. This group was evenly distributed 
between males and females, each having eight cases. Table 3 shows the distribution of 
cases into age and sex (n=84). 
Table 3: Distribution of patients according to age and sex. 
age <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ 
male 3 4 0 6 2 19 8 2 3 3 2 2 
female 0 1 1 0 3 8 8 1 0 2 3 2 
total 3 5 1 6 5 27 16 3 3 5 5 4 
The majority of these patients were admitted to Christchurch Public Hospital (n=52), 
with one patient being an overseas traveller. Patients from the Ashburton region 
reported the second largest number of cases in this study. No information was gathered 
as to a possible source of infection for these patients. It has been assumed that these 
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cases were sporadic, therefore proving difficult to pinpoint a source. C. jejuni isolate 
MB200L, isolated from blood, also had a correlating sample taken from the patient's 
faeces, MB321A. This patient was a 23-year-old male, admitted to Christchurch Public 
Hospital. It is likely that the patient suffered from a severe case of gastroenteritis, 
and/or may have suffered complications. The other two blood samples, R923 and SOS2, 
were isolated from the blood of two other patients. R923 was an 80 year old male, 
while S052 was a 39 year old female. Both patients were from Christchurch, providing 
an isolate only from blood. 
3.2 CLINICAL ISOLATES: flaA PCR-RFLP ANALYSIS. 
The lOS clinical isolates were examined by PCR-RFLP analysis, using primers specific 
for the flagellin gene jlaA (Nachamkin et al 1993). 88 of 105 isolates (83.8 %) 
generated the expected 1.7 kb amplicon. This represented 72 of the patients, including a 
patient who had provided three isolates. However only one of these isolates generated 
the expected 1.7 kb amplicon. Therefore this patient is also represented in the group 
who did not provide a result (see below). Isolates that did not provide an amplicon were 
retested 2 to 3 times in total, with no result. Annealing temperatures were altered to 
SO°C in an attempt to generate the 1.7 kb amplicon, without success. This sample 
consisted of 13 patients, with two patients providing multiple isolates, and the 
remaining only providing one isolate. One patient had provided three samples, of which 
two (YGOI8S and YG022Q) did not generate a PCR amplicon, and these were included 
in this group. The other patient who provided three isolates did not generate a jlaA 
amplicon with any of the isolates (PH790A, PH844R and PH84SS). Methodology 
using purified DNA was not attempted as a template for PCR analysis. 
All experimental procedures used a positive C. jejuni control strain, NCTC 11168. 
NCTC 11168 resulted in a 1.7 kb amplicon in repetitive trials under the experimental 
conditions. A negative control containing all reagents except a DNA template was used 
and this repeatedly provided no evidence of amplification or contamination. 
Incorporating a positive and negative control provided confidence that the experimental 
conditions had remained the same. Typical results of jlaA-PCR conducted on isolates 
are shown in figure S. 
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Figure 5: Agarose gel showing PCR amplicons generated by primers pg 50 and NR 2. PCR amplicons 
were electrophoresed through a 0.8 % agarose gel. Lane 1 and 9, 1 kb DNA ladder (Gibeo BRL); Lane 2, 
BL821U; Lane 3, ET973Q; Lane 4, IG022P; Lane 5, CA755I; Lane 6, DN031T; Lane 7, negative control; 
Lane 8, NCTC 11168. 
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flaA-PCR positive isolates (n=88) were restriction digested using the enzyme DdeI to 
generate an RFLP profile. Of these 88 isolates, 87 provided a measurable profile (83 % 
of the original sample). Table 4 summarises theflaA types generated in this study. 
Figure 6 is a physical map of the flaA gene from NCTC 11168, showing the location of 
flaA primers pg 50 and NR 2. Also illustrated on this physical map are the two 
conserved regions (CI and C2) flanking the variable region (VI). The DdeI digestion 
sites are indicated throughout the gene. 
DdeI 
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DdeI 
DdeI 
DdeI DdeI 
\ 
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O.2kb 
Figure 6: Physical map of NCTC 11168. The PCR amplicon generated usingflaA primers pg 50 and 
NR 2; DdeI digestion sites, conserved (CI and C2) and variable (VI) regions are shown. 
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Table 4: Summary of isolates examined in this study, including jlaA and gmhA 
classifications. 
LB244Q HFCHL 1 NB 
QZ233U HFCHL 1 NB 
JF124L HFCHL 2 1 
ZF320J HFCHL 2 2 
PF322Q HFCHL 2 2 
ZN474U HFCHL 2 2 
ZN807W HFCHL 2 2 
RE1590 HFCHL 2 2 
EG5460 HFCHL 2 5 
EG761C HFCHL 2 5 
QM664N HFCHL 2 7 
QZ840M HFCHL 2 7 
QZ550A HFCHL 2 7 
LJ155C HFCHL 3 4 
ET973Q HFCHL 3 5 
EX923G HFCHL 3 5 
FD131W HFCHL 3 5 
YU304J HFCHL 3 NB 
MB617S HFCHL 4 3 
EU369T HFCHL 4 6 
KX649A HFCHL 4 7 
KZ3861 HFCHL 4 7 
GF923R HFCHL 5 6 
CR828J HFCHL 5 6 
ZG339F HFCHL 5 NB 
ZJ271C HFCHL 5 NB 
NCTC11168 HFNZRM 6 1 
BL821U HFCHL 6 1 
CE934Q HFCHL 6 1 
CA7551 HFCHL 6 1 
R923 HBCHL 6 1 
S052 HBCHL 6 1 
LT038S HFCHL 6 1 
LS466P HFCHL 6 1 
MB200L HBCHL 6 1 
MB321A HFCHL 6 1 
QP453U HFCHL 6 1 
RE097T HFCHL 6 1 
RF185D HFCHL 6 1 
RC7220 HFCHL 6 1 
ZB632B HFCHL 6 4 
ZP028D HFCHL 7 3 
RC167B* HFCHL 7 3 
LB445E HFCHL 7 NB 
ZB375B HFCHL 9 2 
IG022P HFCHL 9 6 
Chapter III Results 39 
Table 4: Continued ... 
QYI39W* HFCHL 9 F 
RD177L* HFCHL 9 F 
XV898P HFCHL 9 NB 
Y0808T HFCHL 9 NB 
YP567F HFCHL 9 NB 
LC667G HFCHL 13 NB 
YN438B HFCHL 14 1 
YU298M HFCHL 14 1 
HI8810 HFCHL 14 1 
LG430I HFCHL 14 3 
PA268R HFCHL 14 NB 
MZ347T HFCHL 14 NB 
RC7Q3J HFCHL 14 NB 
XX158F HFCHL 16 1 
XM653F HFCHL 16 1 
BM271M HFCHL 16 1 
BN499U HFCHL 16 1 
BV3740 HFCHL 16 1 
CM123F HFCHL 16 1 
CU130P HFCHL 16 1 
HW961T HFCHL 16 1 
RC317T HFCHL 16 1 
XT318V HFCHL 16 NB 
YP502F HFCHL 21 3 
BB193H HFCHL 21 7 
CI115W HFCHL 21 NB 
D0399V HFCHL 21 NB 
LG794W HFCHL 21 NB 
DN031T HFCHL 22 5 
D0332T HFCHL 22 5 
D0291I HFCHL 22 5 
LS897W HFCHL 23 4 
LS785M HFCHL 23 4 
LT973B HFCHL 23 4 
LR181R HFCHL 23 4 
MM539G HFCHL 23 NB 
ZI814K HFCHL 24 1 
ZH604N* HFCHL 25 NB 
ZH6050* HFCHL 25 NB 
ZH606P* HFCHL 25 NB 
ZH641W HFCHL 26 1 
ZI975L HFCHL NB 1 
MD672W HFCHL NB 4 
MC715F HFCHL NB 4 
MC591P HFCHL NB 4 
YG018S HFCHL NB NB 
YG023Q HFCHL NB NB 
Chapter III 
Table 4: Continued ... 
YJ936T 
FZ917J 
ZJ638R 
KV955A 
MS179P 
PH790A 
PH844R 
PH845S 
PD850L 
ZN244B 
PN728G 
QA598G 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
HFCHL 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
Results 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
HF CHL = Human Faeces Canterbury Health Laboratories. 
HB CHL = Human Blood Canterbury Health Laboratories. 
F = Faint RFLP pattern, not distinguishable. 
NB = No PCR Band. 
HF NZRM = Human Faeces, New Zealand Reference Material. 
* = C. coli isolates, as determined by hippurate hydrolysis. 
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Using DdeI 17 different flaA-RFLP profiles were generated. The profiles were 
characterised based on a previous study (Armstrong 1997), not as described by 
Nachamkin. RFLP profiles that were not observed in this previous study were assigned 
a new number in order of observation. For example flaA profiles 21 to 26 were new 
RFLP profiles to this study, the other profiles were observed previously. flaA profiles 
generated in this study are shown in figure 7. flaA profiles were not evenly represented 
in this study. Figure 8 shows the distribution of the Campylobacter isolates by flaA 
profiles. 
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Figure 7: DdeI restriction endonuclease digests of representative jlaA PCR amplicons. Digested 
amplicons were analysed by electrophoresis through a 4 % agarose gel. Panel A: Lanes 1 and 11, 100 bp 
DNA ladder (Promega); Lane 2, jlaA 1 Q0233U; Lane 3, jlaA 2 ZF320J; Lane 4, jlaA 3 FD131 W; 
Lane 5,jlaA 4 EU369T; Lane 6,jlaA 5 CR828J; Lane 7,jlaA 6 NCTC 11168; Lane 8,jlaA 7 RCI67B; 
Lane 9 jlaA 9 IG022P; Lane 10,jlaA 13 LC667G. 
123 4 5 6 7 8 9 10 
Panel :8: Lanes 1 and 10, 100 bp DNA ladder (Promega); Lane 2, jlaA 14 RC703J; Lane 3, jlaA 16 
BN499U; Lane 4,jlaA 21 BBI93H; Lane 5,jlaA 22 D0399V; Lane 6,jlaA 23 MM539G; Lane 7,jlaA 24 
ZI814K; Lane 8,jlaA 25 ZH606P; Lane 9,jlaA 26 ZH641W. 
ChapterID Results 42 
NoRFLP 
IlIflaAl 
IlIflaA2 
DflaA3 
DflaA4 
IlIflaA5 
IIflaA6 
IIflaA7 
1.0% flaA5 IZIflaA9 
3.8% 
IllfIaA13 fIaA23 
4.8% IlIflaA14 
DfIaA16 
Il!IflaA21 
IIIflaA22 
IIIflaA23 
IIIflaA24 
IIIflaA25 
flaA14 flaA13 6.7% IIflaA26 7.6% 1.0% 
DNoPCR 
E1NoRFLP 
. 
Figure 8: Distribution of clinical isolates into flaA classifications. 
The largestjlaA group determined in this study was type 6, with 15 isolates (14.2 % of 
the typeable isolates). This group also included NCTC 11168. jlaA group 2 contained 
11 isolates (lOA % of the typeable isolates), followed by jlaA 16 with 9.5 % (n=10). In 
contrast Armstrong (1997) observed jlaA 1, with seven out of 41 isolates to be the 
largest group. OfthejlaA profiles that were new to this study (ie., 21 to 26) groups 21 
and 23 were the most commonly observed, with 5 isolates (4.8 %) in each. However 17 
out of the 105 isolates were non-typeable, representing the overall largest group. 
In order to analyse the DdeI-RFLP results, DNA fragments were awarded a 1 or 0 
according to the absence or presence of a band at a certain migration distance from the 
well origin. The data generated by these profiles was converted to a dendrogram, to 
show the relatedness between different jlaA groups (figure 9). The x-axis represents 
percent genetic similarity, with 1.0 indicating identical, and 0.0 indicating completely 
unrelated. Figure 9 shows that the two most closely related jlaA groups are 2 and 9 
(70 % similar). At the 30 % similar mark on the dendrogram, seven clusters are 
observed. The clusters are represented by jlaA 3, 21, 22 and 26, which appear to be 
unrelated to the majority of isolates examined. The main body of isolates are further 
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divided into three main clusters, represented by flaA 5 and 14, and the main cluster 
consisting of the remainder of isolates. The main cluster consists of three smaller 
clusters, withflaA 2, 4 and 9 in one group,flaA 13, 16 and 24 in a second group and 
jlaA 1, 6, 7 and 23 in the third. 
The information presented in the dendrogram suggests isolates within the closely related 
cluster have a recent common ancestor. jlaA types that do not fall into this main cluster, 
flaA 3, 5, 14, 21, 22 and 26, possibly deviated from the most commonflaA ancestral 
allele some time ago. The dendrogram generated in this study shows the heterogeneity 
withinjlaA alleles. 
Simpson's index of diversity was used to determine whether theflaA typing method was 
discriminative enough to use as an epidemiological test. According to Hunter and 
Gaston (1988) the higher the D value, the increased chance that a new isolate will be 
able to be classified into an already existing profile. Using the total number of isolates 
that provided an RFLP profile (n=87) a D value of 92 % was calculated. Whereas a 
value of 95 % or better would be ideal showing 95 % confidence,jlaA typing provides a 
level of discrimination adequate to characterise a new isolate. If a D value is calculated 
using the original data set of 105 isolates, 94 % of the time new isolates could be 
classified into an existing category. While this value is higher than when including all 
isolates a large portion of the isolates were unable to provide ajlaA amplicon, and may 
therefore be misleading. 
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Figure 9: Dendrogram illustrating the relatedness of clinical isolates using the flaA gene. 
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3.3 CLINICAL ISOLATES: gmhA PCR-RFLP ANALYSIS. 
The 105 clinical isolates previously examined for flaA were used to determine the 
presence of the gmhA gene. Using primers 96.01 and 94.293, gmhA and a portion of 
waaFwere amplified (Upritchard 1997). Of the 105 isolates 75 (71.4 % of the sample 
size) provided an amplicon of either 900 bp or 1.6 kb. The presence of a 1.6 kb 
amplicon indicated that these isolates (YP502F, LG430I, MB617S, ZP028D and 
RC167B) were likely to possess another gene in addition to gmhA and waaF These 
isolates were classified on the basis of their DdeI -RFLP profile as gmhA 3. gmhA 3 has 
been observed in both C. jejuni and C. coli isolates during this study, therefore does not 
appear to be a characteristic of a particular species. Six isolates failed to generate either 
a 900 bp or 1.6 kb band, but consistently provided multiple bands. This group was not 
subjected to RFLP procedures, as the presence of multiple bands would have made 
interpretation difficult. These isolates were designated gmhA 7. The 900 bp isolates 
were classified according to the RFLP profile provided. 
In all the experimental procedures NCTC 11168 was used as a positive control, 
repeatedly generating the 900 bp amplicon. A negative control containing all the 
reagents except DNA template was used, this repeatedly provided no evidence of an 
amplicon or contamination. 
gmhA-positive PCR amplicons (n=68) were restriction digested using DdeI to generate 
an RFLP profile. 66 isolates (62.9 % of the original sample) provided a distinguishable 
RFLP profile. When two isolates provided a similar profile the gmhA amplicons were 
re-digested and visualised on an agarose gel next to each other. This either confirmed 
identity or if a variation was present. Table 4 summarises the isolates examined in this 
study. 
Figure 10 illustrates physical maps of C. jejuni and C. coli genomes amplified by 
primers 96.01 and 94.293. 
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Figure 10a: Physical map of the gmhA gene in C. jejuni isolate NCTC 11168. The 900 bp PCR amplicon 
generated using primers 96.01 and 94.293 is shown including DdeI digestion sites located throughout the 
amplicon. 
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Figure 10b: Physical map of the gmhA gene in C. coli isolate M275. The 1.6 kb peR amplicon 
generated using primers 96.01 and 94.293 is shown, including DdeI digestion sites located throughout the 
amplicon. 
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Assigning gmhA profiles was done by awarding the first profile observed the 
designation 1 and each new profile labeled with the next consecutive number. The 
RFLP procedure provided a further 6 gmhA profiles (7 including the previously 
mentioned gmhA 7). Figure 11 illustrates the different profiles observed in this study. 
12345 678 9 
Figure 11: Agarose gel photo illustrating the different gmhA profiles observed in this study. Lanes 1 and 
9, 100 bp DNA ladder (Promega); Lane 2, gmhA 1 NCTC 11168; Lane 3, gmhA 2 ZF320J; Lane 4, gmhA 
3 generated by a 1.6 kb amplicon :MB617S; Lane 5, gmhA 4 LS897W; Lane 6, gmhA 5 FD131W; Lane 7, 
gmhA 6 EU369T; Lane 8, PCR amplified multiple band profile designatedgmhA 7 BBI93H. 
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Isolates were unequally distributed into different gmhA types. Figure 12 shows the 
distribution of isolates into gmhA profiles. gmhA 1, which included NCTC 11168, was 
the largest group observed with 30 isolates (28.6 % of the original sample). Of the 
isolates that generated a PCR-RFLP profile, gmhA 5 (8.6 % of the original sample) was 
the second largest group in this study. However the largest equal group included those 
isolates that did not amplify under PCR condition (27.6 %), with 7.6 % of the isolates 
not providing a RFLP profile. These isolates may not have generated the RFLP profile 
as the original PCR amplicon was too faint or the profile was too faint or not present on 
the agarose gel to allow accurate classification into a gmhA category. 
NoRFLP 
7.6% 
8.6% 
Figure 12: Distribution of the clinical isolates into gmhA groups. 
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Dendrograms were generated as per flaA. Figure 13 shows the relationship of the five 
gmhA classifications based on a 900 bp PCR-RFLP profile. gmhA 3 and 7 were 
excluded from this dendrogram as the PCR amplicons generated were not directly 
comparable to the 900 bp amplicon. Figure 13 shows two major classes of the 
Campylobacter gmhA gene. The dendrogram shows gmhA 1 and 5 to be related with 
60 % similarity. These related gmhA types probably share a common ancestral gmhA 
gene. It is difficult to assess whether gmhA 7 shares a common gmhA gene to the 
remaining isolates, as this group repeatedly provided the multiple band profile, 
suggesting a possible divergence in the gmhA gene. The gmhA 3 amplicon, containing a 
third gene is anticipated to have significant differences within the gmhA gene (section 
4.3). 
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Figure 13: Dendrogram illustrating the relatedness of the clinical isolates using the gmhA gene. 
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From these experiments it was possible to determine the degree of discrimination the 
gmhA gene provided and whether it is useful as an epidemiological marker. Using 
Simpson's index of diversity, the isolates that provided an RFLP profile (n=66) 
generated a D value of74 %. This meant that when examining a new isolate, the isolate 
could be classified into a pre-existing gmhA type in 74 out of 100 cases. While this is 
not as satisfactory as jlaA typing it may still be a valuable marker used in conjunction 
withjlaA (section 3.4). However when calculating the D value based on the sample size 
of 105 isolates, 90 % of the time a new isolate should be able to be classified into an 
existing category. Again, as with jlaA, a large portion of this sample was unable to 
provide a PCR amplicon therefore this value may be somewhat misleading. 
3.4 CLINICAL ISOLATES: COMBINED flaA AND gmhAPCR-
RFLP ANALYSIS. 
This section analyses only the isolates that generated both a jlaA and gmhA PCR 
amplicon. From the 105 clinical isolates 70 (66.7 %) generated both ajlaA and gmhA 
PCR amplicon. Included in this number was the control isolate NCTC 11168. From 
these 70 isolates 62 (59 % of the original sample) generated detectable RFLP profiles. 
The aim of this section of the thesis was to determine if the application of a second 
marker, gmhA, an unlinked gene on the Campylobacter genome, was able to further 
discriminate between isolates classified by jlaA. It was observed that a higher level of 
discrimination did occur when gmhA was included in the analysis. For example jlaA 
group 2 contains 11 isolates. Combining the gmhA allele withjlaA typing, jlaA 2 was 
further divided into four subgroups (flaA 2/gmhA 1 (n=I), jlaA 2/gmhA 2 (n=5), jlaA 
2/gmhA 5 (n=2), andjlaA 2/gmhA 7 (n=3)). Clearly an additional marker increased the 
level of discrimination. 
Increased discrimination was observed for a number of jlaA groups. jlaA 4 contained 
four isolates, these separated into 3 subgroups, gmhA 3 (n=I), gmhA 6 (n=l) and gmhA 
7 (n=2). The largest group, jlaA 6 (n=15), could be separated into two additional 
subgroups using gmhA, gmhA 1 (n=14) and gmhA 4 (n=1). Figure 14 is a dendrogram 
illustrating the relationship between isolates combining both gene markers. 
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Figure 14: Dendrogram illustrating the discrimination of isolates using a combined analysis ofjlaA. and 
gmM markers. The first number to the left of the isolate name indicates thejlaA classification, whereas 
the second number indicates the gmM classification. 
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The dendrogram illustrates two major clusters of isolates that are relatively unrelated to 
one another. Isolates ZB375B, GF923R, IG022P, RCI67B, MB617S, EU369T and 
KX649A are in one cluster. The remaining isolates group into the second larger cluster. 
This may suggest different evolutionary histories. 
flaA 22 consisted of three isolates that were obtained from the same hospitalised patient. 
It is not surprising that these 3 isolates typed as the same flaA and gmhA type. This 
group could not be discriminated further on the basis of these two markers, providing an 
internal control for this method. From the data presented here, it appears that one strain 
was responsible for the infection of this patient, not multiple strains. It was often 
observed that multiple isolates from the same patient were indistinguishable. This is not 
to say that another marker could not discriminate between these isolates further, but 
based on the information obtained in this study, they appear indistinguishable. 
Several flaA groups were only represented by one gmhA type and therefore addition of 
this marker to the analysis did not increase overall strain resolution. This may be due to 
the fact that the flaA group only comprised of one isolate or that some isolates only 
generated a flaA profile but not a gmhA profile. The former case is illustrated by flaA 
24, which only comprised of one isolate, ZI814K. The latter case is illustrated by flaA 
16. In flaA 16 (n=lO), nine isolates provided gmhA 1 profile, while the other isolate 
gave no gmhA result. 
The level of discrimination achieved by these two genes when combined was calculated 
using Simpson's index of diversity. Using a sample size of 62 isolates that had provided 
bothflaA and gmhA RFLP profiles a D value of 92 % was calculated. This means that a 
new isolate will be classified into the pre-existing profiles 92 % of the time. This is 
encouraging in that the use of these two markers provide a relatively quick and 
reproducible scheme. However, increased sensitivity would be desirable. 
3.5 MULTILOCUS ENZYME ELECTROPHORESIS (MLEE). 
MLEE procedures were applied to the largest flaA group identified in this study. This 
group, flaA 6, contained 15 isolates. Application of gmhA had not discriminated this 
Chapter III Results 54 
group much further (see below). Therefore MLEE analysis, detecting the presence of 
specific enzymes in an organism, was applied to determine if the isolates were, in fact, 
identical or heterogeneous. 
flaA 6 consisted of 15 isolates including NCTC 11168. gmhA typing further classified 
this cluster into two subgroups, gmhA 1 (n=14) and gmhA 4 (n=I). Two enzymes, 
malate dehydrogenase NAD+ (MDH) and malate dehydrogenase NADP+ (ME) 
(appendix 3), were used to determine strain differences by MLEE. While two other 
studies have reported success with at least nine enzymes (Patton et al 1991, 
Aeschbacher and Piffaretti 1989), due to time constraints only two enzymes were used. 
Two other enzymes, catalase and phe-Ieu peptidase, were trialled without adequate 
results. 
For MLEE to provide satisfactory results, cell numbers of each isolate should be 
approximately 2xl08 cfulml. Cell numbers varied in this experiment from lx107 cfulml 
to 6.7xl08 cfulml; table 5 shows the isolate and corresponding cell numbers. When 
examining the 15 isolates with ME, 13 isolates provided a positive result for this 
enzyme, generating two different alleles. However MB321A and RC7220 returned a 
null result. These were recorded as a null to indicate the possible lack of enzyme in 
these isolates. It was possible that RC7220 may not have had an adequate cell number 
to generate a result. MB321A extracts contained an acceptable number of cells but still 
did not generate a result. Figure 15 shows cellulose acetate plates stained with ME. 
When isolates provided an identical allele profile to one previously observed, the 
isolates were analysed repeatedly to determine if they were identical. From these 
observations (data not shown) it was determined that the isolates recorded as allele 2 
were in fact identical. 
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Table 5: Cell numbers of the isolates used in this study. 
~§~1~ltti&W1l~Ww:W~amj{.~i~W1~f1;§;T~,:~~5j11~~1 
NCTC 11168 1.3xlO 
BL821 U 7x107 
CE934Q 1.9xl08 
CA7551 3xl08 
ZB632B 6xI07 
R923 3x107 
S052 6.7x108 
LT038S 2.9xl08 
LS466P 5xI07 
MB200L I.IxI08 
MB321A 5.5x108 
QP543U 5xl07 
RE097T 6.2x108 
RFI85D 2x108 
RC7220 lxI07 
Chapter III Results 56 
9 
Figure 15a: flaA group 6 isolates visualised on cellulose acetate plates stained with ME. 
Lane 1, NCTC 11168; Lane 2, R923; Lane 3, S052; Lane 4, CA755I; Lane 5, marker; Lane 6, BL821U; 
Lane 7, CE934Q; Lane 8, MB200L; Lane 9, RC7220. 
5 6 7 
Figure 1Sb: jlaA group 6 isolates visualised on cellulose acetate plates stained with ME. 
Lane 1, REO 97T; Lane 2, RF185D; Lane 3, ZB632B; Lane 4, MB321A; Lane 5, QP543U; 
Lane 6, LT038S; Lane 7, LS466P. 
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MDH isozyme analysis revealed that 11 isolates had an enzyme with identical migration 
properties. Three different profiles, representing four alleles, were generated with 
MDH. One isolate (ZB632B) contained a second allele and a third isolate (RC7220) 
had two alleles. Two isolates, MB321A and QP543U, lacked an allele. The isolates 
that did not generate an allele with this enzyme should have enough cells present, 
although MB321A was negative in both trials. QP543U had generated an allele with 
the previous enzyme, therefore the results of MDH indicate a lack of a functional 
enzyme present in this isolate. It may be important to increase the cell numbers of these 
isolates to determine whether cell numbers played a role in the lack of allele generated. 
MB321A a faecal isolate, did not provide results via MLEE, however MB200L, isolated 
from the blood of the same patient was positive in both instances. Further experiments, 
possibly incorporating other enzymes will need to be attempted to determine if an error 
did occur or if these two isolates are different. Figure 16 show cellulose acetate plates 
stained with MDH. 
Isolates that generated an allele identical to one previously observed were analysed 
again to determine identity (data not shown). This procedure allowed accurate 
classification of isolates between cellulose acetate plates. 
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Figure 1611.: jlaA group 6 isolates visualised on cellulose acetate plates stained with MDH. Lane 1, 
NCTC 11168; Lane 2, R923; Lane 3, S052; Lane 4, CA755I; Lane 5, marker; Lane 6, BL821U; Lane 7, 
CA934Q; Lane 8, MB200L; Lane 9, RC7220. 
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Figure 16b: jlaA group 6 isolates visualised on cellulose acetate plates stained with MDH. Lane 1, 
REO 97T; Lane 2, RF185D; Lane 3, ZB632B; Lane 4, MB321A; Lane 5, QP543U; Lane 6, LT038S; 
Lane 7, LS466P. 
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Using MLEE the 14 jlaA 6 isolates could be discriminated into 5 subgroups. Figure 17 
is a dendrogram illustrating the relatedness of these isolates. The x-axis indicates 
percent genetic similarity. It is not surprising that isolate ZB632B is unlinked to the 
other isolates (as shown by the dendrogram). This was the sole isolate that was injlaA 
6 with a unique gmhA classification. Three groups were represented by one isolate. 
QP543U only produced a band for ME therefore being 60 % related to the remainder of 
isolates. RC7220, as mentioned previously, did not appear to have an ME allele and 
gave a unique MDH profile in this sample, therefore being 70 % unrelated to the 
remainder of the jlaA 6, gmhA 1 group. These results show that while ZB632B is 
related by jlaA, the majority of evidence suggests that this isolate is significantly 
different from the remaining isolates in this group. Further the majority of strains (flaA 
6, gmhA 1) appear to be identical, therefore suggesting a clonal link between isolates. 
However more enzymes should be assessed to make any strong conclusions. 
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Figure 17: Dendrogram ofjlaA group 6 analysed by MLEE. 
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3.6 ENVIRONMENTAL (SHEEP) ISOLATES. 
3.6.1 ENVIRONMENTAL ISOLATES. 
C. jejuni isolates (n=20) were obtained from Stan Fenwick and Fasi Ahmed (Massey 
University). These isolates were cultured from sheep and were identified as C. jejuni by 
a range of tests, including hippurate hydrolysis at Massey University. Isolates were 
retested for hippurate hydrolysis at Canterbury University and two isolates, CJS-71 and 
CJS-81, returned a negative result. These isolates may in fact be C. eoli or another 
Campylobaeter spp .. 
3.6.2jlaA TYPING. 
Concurrent to studying the human clinical isolates, 20 C. jejuni isolates from sheep 
were examined using PCR-RFLP of the jlaA gene. Procedures were identical to those 
used for the clinical isolates. Of the 20 isolates, 18 (90 %) generated a 1.7 kb amplicon. 
NCTC 11168 served as a control throughout the experiments. Hippurate hydrolysis of 
the two jlaA PCR-negative isolates (CJS-71, 81) had previously suggested that these 
isolates were not C. jejuni, but possibly another Campylobaeter spp.. Time did not 
permit further analysis of these samples. 
The remaining 18 jlaA amplicons were restriction digested using DdeI to generate a 
RFLP profile. 16 isolates (80 % of the original sample) generated a profile. The two 
isolates that did not generate a RFLP profile were too faint to accurately classify into a 
category, this may be due to the PCR amplicon being too faint or not enough template 
used in the digestion. Table 6 summarises the respective jlaA profiles obtained in this 
study. Four DdeI-RFLP profiles were generated from the jlaA-PCR amplicons from 
sheep. All four of these profiles were observed in the human cases described above. 
The similarity ofjlaA types in the environmental samples to the clinical setting suggests 
that there maybe a limited number of jlaA profiles possible in nature. jlaA 6 was the 
largest group, containing five isolates (25 % of the original sample). jlaA 16 also 
contained five isolates. Figure 18 shows the distribution ofthejlaA profiles. Due to the 
small sample size a dendrogram was not generated. The D value was calculated 
combining the clinical isolates with the environmental isolates. This provided a D value· 
of94 % when a sample size of 125 was used in the calculation. 
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Table 6: Summary of environmental isolates used in this study and 
respective flaA and gmhA classifications. 
CJS-72 Sheep 6 1 
CJS-75 Sheep 6 1 
CJS-74 Sheep 6 F 
CJS-84 Sheep 6 NB 
CJS-85 Sheep 6 NB 
CJS-78 Sheep 14 1 
CJS-79 Sheep 14 1 
CJS-83 Sheep 14 1 
CJS-73 Sheep 16 1 
CJS-77 Sheep 16 1 
CJS-82 Sheep 16 1 
CJS-86 Sheep 16 1 
CJS-87 Sheep 16 1 
CJS-88 Sheep 21 1 
CJS-90 Sheep 21 1 
CJS-89 Sheep 21 3 
CJS-76 Sheep F 1 
CJS-80 Sheep F 5 
CJS-81 Sheep NB 1 
CJS-71 Sheep NB NB 
CJS = Campylobacter jejuni sheep. 
F = Faint RFLP pattern, not distinguishable. 
NB = No PCR Band. 
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Figure 18: Distribution of environmental isolates into flaA classifications. 
3.6.3 gmhA TYPING. 
IIflaA 6 
IIflaA14 
DflaA16 
DflaA21 
II No PCR 
II No RFLP 
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Of the 20 isolates three did not generate a PCR amplicon using gmhA. This included 
one isolate (CJS-71) that had not generated an amplicon under flaA, therefore this 
isolate may be C. coli or another thermophilic Campylobacter. Whereas CJS-81 
generated a 900 bp amplicon with gmhA. One isolate CJS-89 provided a 1.6 kb 
amplicon suggesting the possibility of a third gene as seen in clinical isolates YP502F, 
LG430I, MB617S, ZP028D and RC167B. The remaining isolates generated the 900 bp 
amplicon previously observed in the clinical experiments. 
17 gmhA amplicons (85 % of the original sample) were restriction digested using DdeI 
and an RFLP profile was generated for 16 (80 %) of the isolates. CJS-74 was not 
classified under DdeI-RFLP analysis as the profile generated was too faint to accurately 
assign to a category. DdeI-RFLP analysis of CJS-89 generated a gmhA 3 profile, this 
had been observed in the clinical isolates that had generated the 1.6 kb amplicon. Table 
6 summarises the isolates used in this study and their respective gmhA classification. 
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Three gmhA profiles were observed from the environmental isolates, these were 
gmhA 1, gmhA 3 and gmhA 5. These profiles had previously been observed in the 
clinical isolates, therefore suggesting no variation in gmhA alleles at least on a gross 
restriction enzyme scale between sheep and those found in humans. As observed in the 
clinical experiments gmhA 1 contained the largest number of isolates, with 14 (70 % of 
the original sample). Only 1 isolate (5 %) fell into the gmhA 5 category. Figure 19 
shows the distribution of the gmhA profiles amongst this group. A dendrogram was not 
generated as the profiles observed in the environmental isolates were previously 
observed in the clinical isolates, therefore no additional information would have been 
provided by the dendrogram. Combining the environmental samples with the clinical 
isolates, a D value was calculated. With a sample size of 125 isolates, 86 % of the time 
a new isolate will be able to be classified into an existing category using gmhA as a 
marker. This is not as satisfactory as flaA. 
gmhA5 
5% 
gmhA3 
5% 
NoRFLP 
5% 
Figure 19: Distribution of environmental isolates into gmhA classifications. 
IIIgmhA 1 
IIgmhA3 
DgmhA5 
DNoPCR 
II No RFLP 
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3.6.4 COMBINED flaA AND gmhA PCR-RFLP. 
Of the 20 C. jejuni sheep isolates, 16 (80 %) provided a PCR amplicon for bothflaA and 
gmhA. Of these 16 isolates, 13 (65 % of the original sample) had generated an RFLP 
profile. Three isolates (CJS-74, 76 and 80) generated faint RFLP profiles for eitherflaA 
or gmhA, therefore these isolates could not be accurately characterised. The ability to 
discriminate the environmental isolates further with flaA and gmhA combined was not 
as satisfactory as in the clinical isolates. Of the 13 RFLP positive isolates, there were 
four flaA groups, with 12 isolates represented by the same gmhA classification, gmhA 1. 
The remaining isolate, CJS-89, was classified as gmhA 3. 
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CHAPTER IV 
DISCUSSION 
4.1 ISOLATE INFORMATION. 
Campylobacteriosis caused by C. jejuni is one of the most common causes of bacterial 
gastroenteritis worldwide and has been a notifiable disease in New Zealand since 1980. 
The number of notified cases in New Zealand are increasing on a yearly basis. 
Campylobacteriosis is reported to be higher in males than females and primarily affects 
the very young (1-4 year oIds) and young adults (20-29 year oIds) (AlIos and Blaser 
1995, Butzler and Skirrow 1979, Blaser and Reller 1981). At an estimated cost of 
$582,194 for the Canterbury region in 1995 and $4.48 million nationally this organism 
is of great interest to public health (Withington and Chambers 1997). 
The number of isolates collected per month in this study ranged from 1 to 23, with an 
average of9.5 cases per month. During this study December 1997 (n=23) recorded the 
highest number of cases at Christchurch Public Hospital. In January 1998 (n=12) the 
number dropped, before increasing again in February 1998 (n=18). However, it was 
observed that the number of cases reported to the Southern Regional Health Authority 
increased in December 1997 (n=130), with January 1998 reporting the largest number 
of cases (n=195), before decreasing again in February 1998 (n=160). 
The trends reported in the literature (Brieseman 1994) regarding sex disposition and age 
were in general observed in this study. It was found however, that the second most 
prevalent category in this study was 30-39 year oIds, consisting of eight males and eight 
females. A higher number of cases may be reported from this age group for several 
reasons; they maybe more likely to seek medical attention in order to continue 
employment or be more severely affected. The 1-4 year age group may also be under-
represented for numerous reasons. Infants may experience general diarrhetic illness at a 
higher frequency than other age groups, so parents may be more willing to take "a wait 
and see approach" to the disease outcome. 
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Cases of campylobacteriosis in this study were analysed for a temporal and 
geographical linle In one instance, three cases from Ashburton, involving two males 
(ZN474U and ZN807W) and one female (ZN244B) of approximately the same age, 
were collected within one week of each other. While no epidemiological data regarding 
source of infection was reported, this study observed that the two males had an identical 
strain of C. jejuni. The isolate collected from the female did not generate a result, 
therefore it can not be concluded to be identical to that of the males. It was also 
observed that in December 1997, two cases of campylobacteriosis were reported from 
26 year old males from Kaiapoi. Both cases generated the same jlaA and gmhA RFLP 
profiles, strongly suggesting the same strain was responsible for both illnesses. 
Cases of campylobacteriosis are often sporadic in nature, however it is possible that 
under-reported outbreaks may occur. Stehr-Green et al (1991) investigated two reported 
cases of campylobacteriosis in Canterbury during 1990. Both of these cases were 
linked to a camp and convention center in Canterbury. Due to epidemiological and 
microbiological investigations, a further 42 cases were identified. This investigation 
illustrates the potential occurrence of under-reported outbreaks. During the present 
study the three previously mentioned cases from Ashburton may be an example of an 
unreported outbreak, of which more cases were not notified. 
In the present study 15 patients provided more than one isolate during the course of 
their illness. When examined by jlaA and gmhA PCR -RFLP analyses, each isolate that 
generated a profile was shown to be identical to isolates from the same patient. This 
suggests that only one strain was responsible for these infections. While the sample size 
is clearly limited, jlaA/ gmhA PCR methods should be able to provide insight into the 
ecology of C. jejuni in a human host. 
4.2 CLINICAL TYPING USING flaA. 
Clinical differentiation of C. jejuni and C. coli strains has been based solely on the 
ability of C. jejuni to hydrolyse hippurate, whereas C. coli does not. This test is 
somewhat subjective as hippurate negative C. jejuni strains are occasionally observed 
(Totten et al 1976). Campylobacter spp. are relatively inert with regard to routine 
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biochemical tests used for species identification. The detection and identification of 
these organisms by PCR is now being recognised as a reliable alternative to the 
traditional tests (Harmon et al1997). 
A suitable typing system for bacterial isolates needs to be robust, highly reproducible 
and have a high discriminatory power. Fischer and Nachamkin (1991) observed 
differences in the nucleotide structure of the flaA gene in C. jejuni, indicating that this 
gene could be exploited as an epidemiological marker. Nachamkin developed a typing 
system based on PCR-RFLP analysis of the flagellin gene, flaA, observed in C. jejuni 
and C. coli. The amplicon generated by this combination of flaA primers was 
approximately 1.7 kb; when this amplicon was examined using the restriction enzyme 
DdeI in RFLP analysis, distinctive profiles were generated. Comparison of the DdeI 
generated RFLP profiles forms the basis of Nachamkin's system. flaA gene analysis 
was found to be highly reproducible in the isolates that generated results, robust and 
provided a high level of discrimination in the present study. 
flaA-RFLP profiling is increasingly being used as a typing method for epidemiological 
studies (Nachamkin et al 1996, Owen et al 1994, Meinersmann et al 1997). Most 
studies note the usefulness and high level of discrimination that PCR-RFLP analysis of 
the flaA gene provides. On the basis of these observations this technique was chosen 
for the present study. flaA typing had previously been applied to Campylobacter 
isolates obtained from hospitalised patients at Princess Margaret Hospital, Christchurch 
(Hasse et al 1995), and sporadic C. jejuni cases from the human environment 
(Armstrong 1997). This method provided a useful means to determine the extent and 
classification of flaA groups in the Christchurch Public Hospital environment during 
this study. 
83.8 % of 105 isolates from 84 patients generated the expected 1.7 kbflaA amplicon. 
As noted previously (Comi et al 1996, Fischer and Nachamkin 1991) it is not possible 
to separate C. jejuni and C. coli by flaA. These observations were supported in the 
present study. C. coli isolates RC167B typed asflaA 7, while QY139W and RD177L 
typed asflaA 9. As both of these profiles were observed in isolates of C. jejuni, it was 
not possible to distinguish between species. In this study isolates that tested hippurate 
positive were considered to be C. jejuni. Use of a second genetic test, possibly 
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amplification of species specific regIOns of the 23S rRNA could be used for 
confirmation ofthejlaA hippurate positive isolates as C. jejuni. 
Nachamkin et al (1996) found that 85 % of the 404 isolates tested were amplified by 
jlaA -PCR using chromosomal templates extracted by boiling whole cells. This 
procedure is simple to perform, but is dependent on inoculum size, as too much 
inoculum (>50,000 cells) can inhibit the PCR reaction. PCR procedures in the present 
study involved the lysis of bacteria in a Corbett thermal sequencer before the addition of 
Taq polymerase and PCR reaction buffer. It is possible that the amount of cells used for 
PCR could have inhibited the PCR reaction. This remains a possibility for the 17 
isolates not generating the expected amplicon. 
The classification of RFLP profiles in this study was not as previously described by 
Nachamkin. Due to the expense and unavailability of the ProRFLP image analysis 
software, the results of this study were unable to be directly compared to Nachamkin. 
Nachamkin et al (1996) described 83 jlaA types based on 404 C. jejuni and C. coli 
isolates. It is possible that the current 17 types observed in this study fall into this 
existing system although some isolates may represent a unique jlaA type. It may be 
useful for future reference to compare the database ofjlaA types generated by this study 
with those described by N achamkin. Eleven of the jlaA types identified had previously 
been observed by Armstrong (1997), however six were new to this study. 
The jlaA types identified in this study illustrate that there is not one particular C. jejuni 
or C. coli strain responsible for human and animal infection. From these results it 
appears a number of jlaA types of C. jejuni and C. coli are responsible for infection. 
However it was observed that some strains (e.g., jlaA 6) were isolated at a greater 
frequency from humans and animals than others during this study. Armstrong (1997) 
observedjlaA 1 (n=7 from a sample size of 41) to be the most common type identified 
from isolates obtained from human faeces at MedLab South Ltd, Canterbury, during the 
summers of 1995/96 and 1996/97. jlaA 6 (n=2) was equal to jlaA groups 3, 4 and 5, 
therefore not supporting the trend of the present study, although low sample sizes were 
involved. 
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NCTC 11168 was typed in the present study as flaA 6 and this strain is classified as 
HS:2 according to Penner serotyping. In Nachamkin's typing system NCTC 11168 is 
classified as flaA 7 (Nachamkin et al 1996). While NCTC 11168 is HS:2, it is not 
known whether the remaining isolates in this group are also HS:2. In Nachamkin's 
study flaA 7 also contained isolates typed as HS: 1, HS: 10 and HS: 17, therefore it 
appears that this group is relatively heterogeneous. Those isolates typed asflaA 6 in the 
present study may classify into different HS serotypes. 
Dendrogram analysis suggests that closely related isolates have derived from a common 
ancestor. flaA 3,21, 22 and 26, which are not closely related to the main cluster (over 
70 % unrelated), appear to have deviated from a common ancestor some time ago. 
Wassenaar et al (1995) observed that C. jejuni has substantial genetic diversity within 
the flagellar region. They demonstrated recombination within the genome, as well as 
recombination after the uptake of exogenous DNA. flaA and flaB are highly similar, 
therefore subject to intergenic recombination. This recombination may explain the 
presence of 17 different flaA types in this study. Due to horizontal gene transfer" or 
intergenic recombination, assessment of clonality of isolates may be difficult (section 
4.7). 
4.3 CLINICAL TYPING USING gmhA. 
LPS is used as the basis of the heat stable (HS) serotyping scheme of C. jejuni, 
identifying up to 60 serotypes (Aspinall et al1993a, Moran et al1991). LPS molecules 
contain considerable serological heterogeneity between isolates (Beer et al 1986, Perez-
Perez et al 1985). The gmhA gene identified in C. jejuni and C. coli by Upritchard 
(1997) was observed to have heterogeneity between two strains examined. On the basis 
of this research, the gmhA gene was chosen to act as a second marker in the present 
study. The recently submitted whole genome sequence of NCTC 11168 (Sanger) 
clearly indicates that gmhA is unlinked to the flaA gene, therefore any result generated 
by this second marker, gmhA, should discriminateflaA further. 
Of the 105 clinical isolates examined using primers specific for amplification of the 
gmhA gene and a portion of the waaF gene, 71.4 % of the sample generated either a 
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900 bp, 1.6 kb fragment or a multiple band profile. There were five isolates that 
generated a 1.6 kb amplicon. One isolate, M275, has recently been described as C. coli. 
During the course of sequencing and analysis ofwaaFfrom M275 a second gene, which 
had sequence identical to the lex2B gene of H injluenzae (Jarosik and Hansen 1994) 
was observed. Upritchard (1997) also showed that gmhA was linked to lex2B. This 
gene was not present in all isolates examined in this study. Work in the laboratory is 
currently under way to characterise this gene, however this is out of the scope of the 
present study. The majority of isolates examined generated the anticipated 900 bp 
fragment, indicating a lack of the lex2B gene. 
Isolates that generated a 1.6 kb amplicon under PCR conditions were restriction 
digested with DdeI and classified as gmhA 3. This classification was observed in both 
C. jejuni and C. coli, therefore suggesting it was not a characteristic of either species. 
On the basis of the presence of a 1.6 kb amplicon, these isolates were assumed to 
contain the lex2B gene. 
Six of the isolates examined generated a multiple band profile (designated gmhA 7) 
under PCR conditions. These isolates were examined a second time generating the 
same result. These isolates were not subjected to RFLP analysis as interpretation of the 
profile would have been meaningless. When comparing RFLP profiles it is important 
that amplicons of the same size are compared. With gmhA 7 generating a multiple band 
profile, RFLP analysis would not have allowed accurate and equal comparison with 
those of 900 bp. 
Isolates with a clean 900 bp amplicon were restriction digested with DdeI. Analysis of 
the 900 bp isolates generated a further 5 PCR-RFLP profiles. As the present study was 
the firs,t to use gmhA as a marker, no previous classifications for RFLP profiles existed. 
It was therefore decided to assign each profile in the order they were observed. 
gmhA has been observed in E. coli, Haem oph ilus, Helicobacter, Neisseria and other 
Gram-negative prokaryotes, The gmhA gene is likely to be present in all C. jejuni and 
C. coli isolates, including those classified as gmhA 7 in this study. gmhA has been 
identified to encode for the enzyme involved in the first step of the heptose biosynthesis 
pathway ofLPS. However as yet it is not proven whether gmhA is present in all isolates 
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of C. jejuni and C. coli, it would seem likely that this gene would be present. For those 
isolates that did not generate an amplicon, it is possible that gene transfer or mutations 
have altered the primer binding sites, therefore producing a null result. 
This method also proved to be highly reproducible in the isolates that generated the 
PCR amplicon, as well as being robust and relatively simple and rapid to perform. 
However not all isolates were able to provide a positive result. A majority of the 
isolates that had not provided ajlaA amplicon were also not able to generate the gmhA 
amplicon. This may support the assumption that these isolates are not C. jejuni or 
C. coli, but may be another Campylabacter spp .. 
4.4 COMBINATION OF flaA AND gmhA TYPING. 
On its ownjlaA served as a suitable marker for epidemiological studies. Examining the 
gmhA gene from the same sample did not provide the same level of discrimination. 
However a combination of these two genes results in a higher level of discrimination. 
From these experiments a combination of two or more unlinked genes should serve as 
better epidemiological markers than examining only one gene, as has so often been the 
case. Comi et al (1996) used only one gene, jlaA, but on the basis of RFLP profiles 
generated by two different enzymes it was possible to discriminate isolates further. In 
their study they observed the possibility of developing a technique whereby multiple 
restriction enzymes (REs) may be used to distinguish C. jejuni from C. coli. However 
conservation of gene sequences would be reflected by both REs. By examining two 
unlinked genes with the same RE it was possible to develop a greater understanding of 
the true relationship of the isolates. However horizontal gene transfer of one gene may 
still obscure "true" results. 
Amplification of both genes is reproducible and robust. PCR amplification ofjlaA and 
gmhA can often be performed together as the cycling conditions are identical, only the 
primers differ. Often one isolate was examined for both genes simultaneously, 
preparing two tubes with all the reagents and their specific primers. This procedure 
allowed rapid results to be achieved. Multiplexing, the incorporation of all reagents into 
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one tube, including primers specific for both genes, was not attempted in this study. 
Amplicons generated by this technique would have been difficult to separate if an 
isolate generated both a 1.7 kb jlaA and 1.6 kb gmhA amplicon. The combination of 
two fragments would also have generated too many RFLP fragments to allow accurate 
classification. Therefore it was chosen to examine these two genes separately. 
4.5 LEVEL OF DISCRIMINATION. 
The capability of an epidemiological marker to discriminate between isolates is 
important. In the present study jlaA was observed to have a D value of 92 % with 
isolates that provided an amplicon. gmhA provided a D value of only 74 %. When 
these two genetic markers were combined a D value of 92 % was observed. While this 
is the same as jlaA alone, further examination found that discrimination of isolates had 
indeed occurred. Owen et at (1994) observed that a combination ofjlaA profiling with 
either serotyping or biotyping increased discrimination of isolates. These observations 
were supported in the present study. 17 jlaA types were further discriminated into 22 
types by the addition of gmhA. 
4.6 MULTILOCUS ENZYME ELECTROPHORESIS (MLEE). 
As was observed with combination of the two markers,jlaA and gmhA, upon addition of 
MLEE, the level of discrimination between isolates increases. Due to the time 
constraints on this study only a small sample was examined by a second genetic test, 
MLEE. It was decided to examine the largestjlaA group,jlaA 6. 
With the analysis of two enzymes used for MLEE it was possible to discriminate these 
15 isolates into a further four groups, with 11 isolates appearing identical, therefore 
suggesting possible relatedness or similarity to each other. However, as has been 
evident from the previous experiments, the. more markers applied to a subset of isolates 
the more likely the chance of discriminating between them increases. If a further 5-8 
enzymes were examined using MLEE it should be possible to divide this group into 
only a few isolates per cluster, unless the isolates truly are identical. This procedure 
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however, would be expensive. MLEE proved to have a high level of discrimination, but 
was a time consuming technique. 
4.7 GENE TYPING VS GENOME TYPING. 
The flagellar region of C. jejuni has been shown to experience recombination and 
horizontal gene transfer (Wassenaar et al 1995, Harrington et al 1997). With the 
demonstration of genetic recombination between flagellin genes, a number of outcomes 
need to be considered. With recombination an increased immunogenic repertoire will 
be observed, however this raises questions as to the stability of the flagellin gene as a 
genetic marker (Harrington et al 1997). While recombination can occm within or 
between flagellin loci, genotypically the organism may remain unaltered. Therefore 
relationships determined by flagellin gene typing may not accmately reflect true clonal 
relationships, as would be determined by other genotypic methods (Harrington et al 
1997). 
Horizontal gene transfer may provide an isolate with a "new" flaA gene, possibly from 
another species, therefore making comparisons of the flaA gene difficult (Harrington et 
al1997). 
Recombination and horizontal gene transfer may also be possible for the gmhA gene. 
The closely related groups indicate that they have diverged from a common ancestor, 
while the other types, gmhA 3/gmhA 7, may have diverged some time ago. Harrington 
et al (1997) observed horizontal gene transfer in isolates of C. jejuni. They assumed 
that recombination had occurred in a one year period, therefore suggesting recent or 
modem evolution of the gene. The gmhA gene may have under gone a modem 
recombination event. As withflaA, it has not been determined whether recombination 
or horizontal gene transfer has occurred in the isolates examined in this study. Fmther 
experiments would need to be carried out to test this hypothesis. 
Genome typing appears to be more reliable than gene typing as it measures 
chromosomal differences. The chromosome is more stable than individual genes, which 
are subject to recombination. Genotypic results have the potential of providing a more 
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consistent and reproducible result than biochemical and phenotypic tests. However, 
genotypic techniques are complex and time consuming, often involving specialised 
reagents, equipment and staff (Patton et alI991). 
Researchers have applied many different typing methods to Campylabaeter spp.. In 
New Zealand at the Communicable Disease Center, serotyping, biotyping and macro-
restriction fragment length polymorphisms using PFGE were trialled. No one method 
was found to be ideal (Nicol and Wright 1997). An international standard of typing 
methods needs to be developed to allow accurate and consistent classification and 
comparisons of Campylabaeter spp .. 
4.8 ENVIRONMENTAL (SHEEP) TESTING. 
4.8.1flaA TYPING. 
DdeI PCR-RFLP analysis of 20 C. jejuni isolates from sheep generated four profiles 
previously observed in the human population. In a study ofjlaA types found in humans, 
chicken, sheep and bovine, Owen et al (1994) observed a commonflaA type amongst 
all groups. This supports the observations of the present study that C. jejuni strains are 
present in both the human and sheep populations. Therefore, it was not surprising that a 
new flaA type was not identified amongst the sheep isolates examined in this study. 
However if a larger sample size was examined it may be possible to identify aflaA type 
that is unique to the animal population. 
4.8.2 gmM TYPING. 
The 20 isolates were also analysed using gmhA PCR-RFLP procedures. Of the 20 
isolates 17 (85 %) generated an amplicon, with one classified as gmhA 3 (CJS-89). No 
isolates generated the multiple band profile (gmhA 7) under PCR conditions. PCR-
RFLP analysis generated three gmhA profiles, all previously observed in the clinical 
isolates of this study. As was observed in the clinical isolates, gmM 1 was the largest 
gmM class represented in this study. 
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4.9 CONCLUSIONS. 
This thesis identified and characterised strains of C. jejuni and C. coli that were present 
in a specific human population using molecular techniques to establish whether isolates 
were unique to both hospital/non-hospital and environmental populations. 
Many researchers have reported the usefulness of flaA PCR-RFLP analysis as an 
epidemiological marker. The present study found this technique to be highly 
reproducible and discriminative and with the addition of a second gene, gmhA, 
discrimination improved. It was observed that isolates of C. jejuni and C. coli are not 
able to be distinguished via flaA typing, supporting the observations of Comi et al 
(1996). 
The results of this study highlight the advantages of using two genetic markers to 
identify the isolates of C. jejuni and C. coli responsible for causing gastrointestinal 
illness. By understanding what strains are prominent at causing disease it may be 
possible to target a vaccine at the most common types. The isolates in this study were 
collected from hospitalised patients which in theory, would be more virulent than strains 
observed in the community. 
This study identified six new flaA types that were not observed by Armstrong (1997). It 
may be possible that these strains are more likely to be present in the hospital 
environment. Alternatively, these results may indicate a shift in strains present in the 
environment. Armstrong's study was based in the summers of 1995/96 and 1996/97, 
therefore direct comparisons are difficult. It would be ideal to compare the results of 
the present study with isolates from the community during the same period of time. 
This may determine whether the hospital isolates are different from the community, or if 
a shift has occurred since Armstrong's study. A survey of strains present in the general 
community at the same time is currently underway to address these questions. 
A secondary aim of this study was to identify the strains present in a hospital 
environment and generate a database to allow accurate and consistent comparisons to be 
made to future and past experiments. This study identified common strains of C. jejuni 
Chapter IV Discussion 77 
and C. coli present in the hospital environment during 1997/98, observing that a 
dominant type (flaA 6) was present in both the hospital and animal environment. flaA 
14, 16 and 21 were also observed in both environments. Therefore it could be 
concluded from this study that some strains of C. jejuni were restricted only to a human 
population, however a larger sample size needs to be examined to support these 
observations. 
This study also illustrated the usefulness of flaA and gmhA as a rapid means for 
identifying a possible outbreak source. As mentioned previously the three cases from 
Ashburton may indicate an unreported outbreak. 
This study used two different genetic tests that provided reproducible, robust and 
discriminative results. Levels of discrimination were high, with each subsequent test 
providing further discrimination to the isolates examined. 
4.10 FUTURE EXPERIMENTS. 
Future experiments would include 23 S rRNA analysis of the isolates that did not 
amplify under flaA or gmhA peR conditions. This would determine whether these 
isolates were C. jejuni, C. coli or another thermophilic Campylobacter spp.. If they 
proved to be C. jejuni or C. coli further examination to see what prohibited 
amplification using flaA specific primers may provide some answers. For example, 
sequence analysis could be performed to determine if heterogeneity around the primer 
binding sites exists preventing the primers from annealing and therefore generating an 
amplicon. 
Other experiments could also include the analysis of the remaining isolates with MLEE 
to determine the distribution in the original sample. More enzymes would be important 
to examine, as this may provide a further understanding of the distribution of isolates in 
the clinical environment. The MLEE technique could also be applied to the 
environmental isolates to determine if they are identical to that observed in the clinical 
isolates. MLEE analysis of the environmental samples may allow further 
discrimination to determine whether the strains examined in a hospital population are, in 
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fact, present in an animal environment. By using MLEE analysis the discrimination of 
the classification scheme developed in this study could increase further. 
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APPENDIX I 
MEDIA 
I.i. GENERAL MEDIA. 
Unless otherwise stated, all media were sterilised by autoclaving for 20 minutes, 121°C 
at 120 kPa. Solutions that were labile at this temperature were filter-sterilised through a 
0.22 )lm filter prior to addition to sterile media. 
Campylobacter Blood-Free Selective Agar Base (Modified CCDA-Preston) 
Per litre 
2.5 % w/v Oxoid Nutrient Broth No.2 
0.4 % w/v bacterial charcoal 
0.3 % w/v casein hydrolysate 
0.1 % w/v sodium desoxycholate 
0.025 % w/v ferrous sulphate 
0.025 % w/v sodium pyruvate 
1.2 % w/v agar 
25 g 
4g 
3g 
1 g 
0.25 g 
0.25g 
12 g 
Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. After sterilisation, 1 ml 
of cefoperazone solution (3.2 mg/l) was added to the medium. 
Mueller-Hinton Agar 
30 % w/v beef infusion 
1.75 % w/v acid hydrolysate of casein 
0.15 % w/v starch 
Per litre 
300 g 
17.5 g 
1.5 g 
1.7 % w/v Bacto-agar 17 g 
Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. For culturing of 
Campylabaeter, defibrinated sheep blood (5 %) was added after autoc1aving. 
Appendix I Media 
Brain Heart Infusion Broth 
Typical formula (giL): Per litre 
Beef heart infusion 25 g 
Calf brain infusion 20 g 
Protease peptone 10 g 
NaCI 5g 
Na2HP04: 12H2O 2.5 g 
Glucose 2g 
Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. 
Nutrient Broth No.2 
Typical formula (giL): 
Beef extract 
Peptone 
NaCI 
per litre 
10 g 
10 g 
5g 
Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. 
Nutrient Broth No.2 Agar 
Typical formula (giL): 
Beef extract 
Peptone 
NaCI 
Bacteriological agar 
per litre 
10 g 
109 
5g 
15 g 
Dissolved in dH20 and pH adjusted to 7.4 before auto cl aving. 
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APPENDIX II 
BUFFERS AND SOLUTIONS 
II.i. COMMON BUFFERS 
Solutions requiring sterilisation were either autoclaved for 20 minutes at 121°C at 120 
kPa or filter-sterilised through a 0.22 JlIIl filter. All solutions were stored at ambient 
temperature unless otherwise stated. 
50xTAE 
2.5 M Tris base 
0.11 % w/v Glacial acetic acid 
50 mMNa2EDTA (PH 8.0) 
per litre 
242 g 
57.1 ml 
46.5 g 
Dissolved in dH20 to fmal volume of 1 litre, pH adjusted to 8.0 
lxTAE 
20 ml of 50 x TAE dissolved in ddH20 to a final volume of 1 litre. 
6 x DNA Loading Buffer for Agarose Gel Electrophoresis 
50 % v/v Glycerol 
0.25 % w/v Bromophenol blue 
0.25 % w/v Xylene cyanol FF 
Dissolved in dH20. 
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APPENDIX III 
MLEE BUFFERS AND ENZYMES 
Extraction Buffer (Selander et a11986) 
10 mM Tris HCI 
1 mMEDTA 
0.5mMNADP 
47.15 ml dH20 
Make up to 50 m!. Adjust pH to 6.8 
Agar Overlay (adapted from Hebert and Beaton 1989) 
4 g Bacteriological agar 
250 ml dH20 
91 
Heat the mixture until it boils vigorously. This is most easily accomplished by heating 
for 2-3 min in a microwave on full power. Store covered at 60°C between uses. 
Tris Glycine (TG) Buffer (Hebert and Beaton 1989) 
30 g Tris base 
114 g Glycine 
Make up to 1 litre with dH20. 
Dilute 1:9 [TG:dH20] for general use. 
Adjust to appropriate pH (e.g., 7.5) with concentrated HCL. 
Tris maleate (Catalase Electrode Buffer) (Aeschbacher and Piffaretti 1989) 
12.1 g Tris base 
11.6 g Maleic acid 
3.72 g disodium EDTA 
2.03 g MgCh:6H20 
Make up to 1 liter with dH20. 
Adjust to pH 7.0 and 7.5 with concentrated NaOH. 
Appendix III MLEE: Buffers & Enzymes 
Malic substrate (200 ml stock solution) 
180 ml dH20 
20 ml Tris HCI, pH 9.0 
3.68 g L-Malic acid 
Add ingredients sequentially and mix. Adjust to pH 8.0. 
NAD (Stock Solution) 
2mg/ml 
Make up to 30 ml with ddH20. 
NADP (Stock Solution) 
2 mg/ml 
Make up to 30 ml with ddH20. 
MTT (Stock Solution) 
10 mg/ml 
Make up to 10 ml with ddH20. 
PMS (Stock Solution) 
2 mg/ml 
Make up to 10 ml with ddH20. 
MgCh (Stock Solution) 
20 mg/ml 
Make up to 10 ml with ddH20. 
O.02M Na2HP04 
200 ml dH20 
0.568 g Na2HP04 
Add ingredients sequentially, adjust to pH 7.5 with concentrated HCl. 
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Appendix III 
1M MnCh 
100 ml dH20 
19.79 gMnCh 
MLEE: Buffers & Enzymes 
Dilute 1:9 for working solution of 100mM. 
Peroxidase (Stock Solution) 
8.62 mg/ml 
Make up to 10 ml with ddH20. 
O-Dianiside (Stock Solution) 
4 mg/ml 
Make up to 10 ml with ddH20. 
L-amino-acid oxidase (Stock Solution) 
10 units/ml 
Make up to 2 ml with ddH20. 
Phe-Leu (Stock Solution) 
10 mg/ml 
Make up to 10 ml with ddH20. 
Malate Dehydrogenase (MDH) (Hebert and Beaton 1989) 
2 ml Tris HCI, pH 8.0* 
3 mi NAD (10 % v/v stock) 
528 j.!l Malic substrate 
220 j.!l MTT (2.2 % v/v stock) 
220 j.!I PMS (2.2 % v/v stock)* * 
2 ml agar 
Add all ingredients sequentially into a MCCartney Bottle and mix gently, add molten 
agar and mix prior to overlaying cellulose acetate plate. 
* Optional ingredient. 
** Labile or photosensitive, add immediately before use. 
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Malate Dehydrogenase NADP+ (ME) (Hebert and Beaton 1989) 
1.2 ml Tris HCl, pH 8.0* 
3 ml NADP (10 % v/v stock) 
528 III Malic substrate 
88 III MgCh (0.9 % v/v stock) 
220 III MTT (2.2 % v/v stock) 
220 III PMS (2.2 % v/v stock) * * 
2 ml agar 
Add all ingredients sequentially into a MCCartney Bottle and mix gently, add molten 
agar and mix prior to overlaying cellulose acetate plate. 
Peptidase (PEP) (Hebert and Beaton 1989) 
2 ml 0.02M Na2HP04 (adjusted to pH 7.5) 
176 III Peroxidase (1.76 % v/v stock) 
352 III o-Dianisidine (diHCI salt) (0.9 % v/v stock) 
88 III MnCh (100 mM stock) 
352 III Peptide (use desired dipeptide, e.g., Phe-Leu) (3.52 % v/v stock) 
176 III L-amino-acid oxidase (8.8 % v/v stock) * * 
2 ml agar 
Add all ingredients sequentially into a MCCartney Bottle and mix gently, add molten 
agar and mix prior to overlaying cellulose acetate plate. 
Catalase (CAT) (Aeschbacher and Piffaretti 1989) 
Incubate cellulose acetate plate for 15 min in 50 ml of a solution containing 1.5 ml of a 
50 % v/v solution of hydrogen peroxide and 750 Ilg of sodium sulfite. 
Decant solution, rinse cellulose acetate plate with H20, and immerse in freshly made 
1.5 % v/v solution of potassium iodide. 
Mix gently and remove stain solution when white zones appear on dark blue 
background. 
* Optional ingredient. 
** Labile or photosensitive, add immediately before use. 
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APPENDIX IV 
S-PLUS 
This computer package is used to design dendrograms illustrating the genetic 
relationship of isolates examined in this study. 
>data<-read. table("a: \filename.csv" ,sep="," ,header=T,row.names=NULL) 
Reads the data from the 3.5" floppy, containing the Excel file saved in a CSV format. 
>data.dist<-dist( t( as.matrix( data[,2 : final column]) ),metric="binary") 
[2:final column] tells S-plus the size of the matrix. 
>data. clust<-hclust( data.dist,method="average") 
Clusters the information created previously. 
>win.graphO 
Opens the graph interface window. Using the Window menu switch back to the 
command window. 
>plclust( data,clust,hang=-l ,labels=names( data[,2 :fmal 
column ]),ylim=c(O, 1 ),main="cluster name") 
95 
Produces the cluster in the graphics window. Using the Window menu you can view the 
cluster. 'main="cluster name'" is what you want to call the cluster. 
>win.printer(file="a:\filename.wmf',h=8.27,w=11.69,format="placeable") 
Opens a new file to be saved in. 
>plclust( data.clust,hang=-l ,labels=names( data[,2 : final 
column ]),ylim=c(O, 1 ),main="cluster name") 
Tells S-plus what to save. 
>dev.offO 
Physically saves the file to the disk. 
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APPENDIX V 
RAW DATA 
Information collected relating to age, sex and geographic location of the patients 
examined in this study. 
(1 to 15 indicate the patients who provided multiple isolates during the course of illness) 
DELPHIC NUMBER AGE SEX (MIF) GEOGRAPHIC LOCATION 
XT318V 90 F CHCH 
XV898P 35 F CHCH 
XX158F 21 M CHCH 
YG018S 1 21 F CHCH 
YG023Q 1 21 F CHCH 
IG022P 1 21 F CHCH 
XM653F 11 M CHCH 
YJ936T 23 M CHCH 
Y0808T 2 64 M CHCH 
YP567F 2 64 M CHCH 
YN438B 78 F CHCH 
YP502F 48 M CHCH 
YU298M 32 F CHCH 
YU304J 10M M SELWYN 
BB193H 25 F CHCH 
BL821U 15 M KAIAPOI 
BM271M 3 35 M WOODEND 
BN499U 3 35 M WOODEND 
BV3740 4 36 F CHCH 
CM123F 4 36 F CHCH 
CE934Q 35 F CHCH 
CA755I 28 M CHCH 
CI115W 3 F RAKAIA 
CU130P 6M M CHCH 
ZB375B 36 M ASHBURTON 
ZB632B 51 M ASHBURTON 
D0399V 28 M OVERSEAS TRAVELLER 
DN031T 5 32 M CHCH 
D0332T 5 32 M CHCH 
D02911 5 32 M CHCH 
EG5460 6 11 M CHCH 
EG761C 6 11 M CHCH 
ET973Q 35 M OUTPATIENT 
EU369T 83 F CHCH 
EX923G 32 F OUTPATIENT 
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FD131W 21M M OUTPATIENT 
ZF320J 33 F ASHBURTON OUTPATIENT 
FZ917J 52 M CHCH 
GF923R 76 F CHCH 
ZG339F 13M M ASHBURTON OUTPATIENT 
CR828J 30 M CHCH 
HI8810 25 F CHCH 
HW961T 20 M LINCOLN\LEESTON 
ZH604N 7 26 M ROLLESTON OUTPATIENT 
ZH6050 7 26 M ROLLESTON OUTPATIENT 
ZH606P 7 26 M ROLLESTON OUTPATIENT 
ZH641W 25 M ASHBURTON OUTPATIENT 
ZI814K 14 M ASHBURTON 
JF124L 31M M CHCH 
ZI975L 16 F ASHBURTON OUTPATIENT 
ZJ271C 23 M ASHBURTON - FROM TAURANGA 
ZJ638R 13 M ASHBURTON OUTPATIENT 
LJ155C 22 M CHCH 
LB445E 6 F CHCH 
LG4301 29 F NTH CANTERBURY 
LG794W 17 F CHCH 
LC667G 30 M CHCH 
LB244Q 10 M CHCH 
KX649A 8 29 M CHCH 
KZ386I 8 29 M CHCH 
KV955A 61 F CHCH 
R923 80 M CHCH 
S052 39 F CHCH 
LS897W 9 26 M KAIAPOI 
LS785M 9 26 M KAIAPOI 
LT038S 80 M CHCH 
LT973B 26 M KAIAPOI 
LR181R 7M M CHCH 
LS466P 22 F CHCH 
MB200L 10 23 M CHCH 
MB321A 10 23 M CHCH 
MB617S 73 M KAIAPOI 
MD672W 11 67 F RANGIORA 
MC715F 11 67 F RANGIORA 
MC591P 11 67 F RANGIORA 
MS179P ? ? ? 
PH790A 12 22 F CHCH 
PH844R 12 22 F CHCH 
PH845S 12 22 F CHCH 
PF322Q 64 M CHCH 
PD850L 27 F CHCH 
PA268R 13 75 F CHCH 
MZ347T 13 75 F CHCH 
MM539G 32 F CHCH 
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ZN244B 27 F ASHBURTON 
PN728G 23 M CHCH 
ZN474U 28 M ASHBURTON 
QA598G 14 M CHCH 
ZN807W 28 M ASHBURTON 
QZ233U 14 32 M CHCH 
RC703J 14 32 M CHCH 
QP453U 26 M KAlAPOl 
QM664N 20 M CHCH 
RE097T 18 M CHCH 
RF185D 13M M CHCH 
QZ840M 15 35 M CHCH 
QZ550A 15 35 M CHCH 
RE1590 68 M CHCH 
RC7220 18 F ASHBURTON 
RC317T 26 M CHCH 
ZP028D 76 M ASHBURTON 
QY139W 53 M CHCH 
RC167B 44 F CHCH 
RD177L 49 M CHCH 
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Data used to generate flaA and gmhA combined dendrogram. 1 indicates presence of a 
band, 0 indicates absence of a band. 1-17 represents flaA type, 18-24 represents gmhA 
type. 
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Data used to generate MLEE dendrogram. 1 indicates flaA 6. 2 indicates gmhA 1, 3 
gmhA 5. 4 ME null result. 5 ME allele 1. 6 ME allele 2. 7 MDH null result. 8 MDH 
allele 1. 9 MDH allele 2. 10 MDH allele 3. 11 MDH allele 4. 
